Metal Selectivity and Acquisition by the Yersiniabactin Metallophore System in Escherichia coli by Koh, Eun-Ik
Washington University in St. Louis
Washington University Open Scholarship
Arts & Sciences Electronic Theses and Dissertations Arts & Sciences
Spring 5-15-2016
Metal Selectivity and Acquisition by the
Yersiniabactin Metallophore System in Escherichia
coli
Eun-Ik Koh
Washington University in St. Louis
Follow this and additional works at: https://openscholarship.wustl.edu/art_sci_etds
Part of the Biochemistry Commons, and the Microbiology Commons
This Dissertation is brought to you for free and open access by the Arts & Sciences at Washington University Open Scholarship. It has been accepted
for inclusion in Arts & Sciences Electronic Theses and Dissertations by an authorized administrator of Washington University Open Scholarship. For
more information, please contact digital@wumail.wustl.edu.
Recommended Citation
Koh, Eun-Ik, "Metal Selectivity and Acquisition by the Yersiniabactin Metallophore System in Escherichia coli" (2016). Arts & Sciences
Electronic Theses and Dissertations. 790.
https://openscholarship.wustl.edu/art_sci_etds/790
WASHINGTON UNIVERSITY IN ST. LOUIS 
Division of Biology and Biomedical Sciences 
Molecular Microbiology and Microbial Pathogenesis 
 
Dissertation Examination Committee: 
Jeffrey P. Henderson, Chair 
Peter M. J. Burgers 
Michael G. Caparon 
James Fleckenstein 
Jennifer K. Lodge 
Timothy A. Wencewicz 
 
 
Metal Selectivity and Acquisition by the Yersiniabactin Metallophore System in Escherichia coli 
 
By 
Eun-Ik Koh 
 
A dissertation presented to the  
Graduate School of Arts & Sciences  
of Washington University in  
partial fulfillment of the  
requirements for the degree  
of Doctor of Philosophy  
 
 
 
 
May 2016 
St. Louis, Missouri 
  
 
 
 
 
 
 
 
© 2016, Eun-Ik Koh 
 ii	  
TABLE OF CONTENTS 
 PAGE 
List of Figures  iii 
List of Tables v 
Acknowledgements vi 
Abstract of the Dissertation viii 
1. Introduction: Microbial copper-binding siderophores at the host-pathogen 
interface 
1 
1.1 Siderophores 2 
1.2 Uropathogenic E. coli siderophores 3 
1.3 Cupric yersiniabactin in human infections 5 
1.4 Structural features of biological copper-binding molecules 6 
1.5 Copper-binding siderophores as a defense against host-derived copper 
toxicity 
9 
1.6 Copper-binding siderophores as a countermeasure against superoxide-based 
host defenses 
11 
1.7 Questions and hypotheses 14 
2. Metal selectivity by the virulence-associated yersiniabactin metallophore 
system 
30 
3. The yersiniabactin-associated ATP binding cassette proteins YbtP and YbtQ 
enhance E. coli fitness during high titer cystitis 
74 
4. Metal acquisition by the virulence-associated yersiniabactin metallophore 
system 
109 
5. Conclusions, Perspectives and Implications 149 
5.1 Summary of the Thesis 150 
5.2 Perspectives on metal availability in the urinary tract 151 
5.3 Implications and outcomes of metallophore transport 152 
5.4 Methodology development and applications 155 
5.5 Concluding remarks 156 
Curriculum Vitae 165 
 
 iii	  
LIST OF FIGURES 
FIGURE  PAGE 
 CHAPTER ONE  
1 Uropathogenic Escherichia coli siderophores 15 
2 Extracellular copper binding molecules 16 
3 Copper-binding siderophore functions at the host-pathogen interface 17 
   
 CHAPTER TWO  
1 Mass spectrometric neutral loss screen reveals multiple stable metal-Ybt 
complexes 
52 
2 MS and MS/MS spectral analyses reveal non-ferric metal-Ybt complexes 53 
3 Density function theory (DFT) models structurally differentiate Cu(II)-Ybt 
complexes 
54 
4 FyuA and YbtPQ are necessary for Fe(III)-Ybt-dependent growth in 
pathogenic (UTI89) and non-pathogenic (MG1655) E. coli 
55 
5 Direct LC-MS/MS detection of cell-associated Fe(III)-Ybt in FyuA-
expressing UTI89 and MG1655 
56 
6 FyuA and TonB-dependent uptake of Cu(II)-Ybt and other non-ferric 
complexes 
57 
7 Cu(II)-Ybt does not competitively inhibit Fe(III)-Ybt uptake 59 
8 Metal-Ybt transport model 61 
S1 Fe(III)-Ybt and apo-Ybt levels do not decrease in presence of excess zinc 
ions 
62 
S2 Structural confirmation of metal-Ybt complexes by stable isotope labeling 63 
S3 Comparison of neutral Fe(III)-Ybt complexes 64 
S4 FyuA and YbtPQ are necessary for Fe(III)-Ybt-dependent growth in UPEC 65 
   
 CHAPTER THREE  
1 Genetic organization of UTI89 Yersinia High Pathogenicity Island (HPI) 91 
2 YbtPQ is required for Fe(III)-Ybt-dependent growth in UPEC 92 
3 YbtPQ is not required for Ybt synthesis in UPEC 93 
4 In vivo single strain infections in C3H/HeN mice background 94 
5 Bladder intracellular bacterial communities at 6 hours post infection in 
C3H/HeN mice 
95 
6 In vivo competitive infection in C3H/HeN mice and in vitro co-culture 
growth 
96 
7 In vivo competitive infections in C3H/HeN mice show correlation with 
bacterial levels 
97 
8 In vivo competitive infection with C3H/HeOuJ mice 98 
9 In vivo single strain infections in C3H/HeOuJ mice backgrounds 99 
 iv	  
   
 CHAPTER FOUR  
1 FyuA and YbtPQ are required and sufficient for Fe(III)-Ybt-dependent 
growth in UPEC 
129 
2 Direct LC-MS/MS detection of supernatant and cell-associated Fe(III)- and 
apo-Ybt in FyuA and YbtPQ-expressing UTI89 
130 
3 Growth of pathogenic E. coli strains under Fe(III)-Ybt-dependent 
conditions 
132 
4 Direct LC-MS/MS detection of Fe(III)- and apo-Ybt from pathogenic E. 
coli culture supernatant 
133 
5 In vitro iron release from Fe(III)-Ybt complexes 134 
6 Direct LC-MS/MS detection of supernatant and cell-associated Ga(III)- and 
apo-Ybt in FyuA and YbtPQ-expressing UTI89 
135 
7 Direct LC-MS/MS detection of supernatant and cell-associated Cu(II)-, 
Ni(II)- and apo-Ybt in FyuA and YbtPQ-expressing UTI89 
137 
8 Direct detection of 64Cu from cellular 64Cu(II)-Ybt 139 
   
 CHAPTER FIVE  
1 Metal transport and delivery by the yersiniabactin metallophore system 158 
 
  
 v	  
LIST OF TABLES 
TABLE  PAGE 
 CHAPTER TWO  
1 Calculated metal-Ybt extinction coefficient values 66 
   
 CHAPTER THREE  
1 UTI89 mutant strains used in this study 100 
 
  
 vi	  
ACKNOWLEDGEMENTS 
This dissertation along with all the scientific and personal growth would not have been 
possible without the support and encouragement of many individuals. First and foremost, I am 
extremely grateful to my thesis mentor, Dr. Jeff Henderson. It is difficult to describe all the 
positive contributions Jeff has made to my development as a scientist. From the very beginning, 
Jeff has brought patience and enthusiasm to allow me to find confidence and think critically in 
the lab. He has always been available with helpful advice and has actively opened new 
opportunities and resources to help pursue my scientific goals. I am truly honored to have been 
his student.  
I am grateful to members of the scientific community at Washington University for their 
expert guidance and support. I thank my thesis committee for their important contributions to 
this dissertation and my scientific career. This dissertation would also not have been possible 
without the kindness and support of the fantastic people I have worked with in the lab. I would 
especially like to thank Dr. Chia Hung for his humor and guidance from the very beginning. I am 
also thankful to Jan Crowley, Hung Tran, Dr. Jonas Marschall, Dr. Kaveri Parker, Dr. Robin 
Shields-Cutler and Shannon Ohlemacher for their enthusiasm, kindness and support. I would also 
like to acknowledge the expertise and kindness of collaborators, Dr. Daryl Giblin, Dr. Nilantha 
Bandara and Dr. Buck Rogers. And to my classmates in the Division of Biology and Biomedical 
Sciences, I am grateful for our friendship over the years.  
I would also like to thank mentors and teachers prior to graduate school whose valuable 
encouragements built the foundations for this thesis. David Hoover and John McCandless 
encouraged me to develop my scientific thinking in high school. Dr. Steven Blanke and Dr. 
 vii	  
Manfredo Seufferheld introduced me to microbial research and provided valuable scientific 
experiences during my undergraduate years.  
I am eternally grateful to my parents, Kwang Ok Koh and Mi Soon Song, and my sister, 
Eunjin Koh for their love and support. I would not be the person who I am today without my 
family. Lastly, I would like to thank my wife, Yu Sun Chung. She has been my greatest source of 
support, friendship and love over the years. I am grateful to share our life journey together.  
 
 
Eun-Ik Koh 
Washington University in St. Louis 
May 2016 
 
  
 viii	  
ABSTRACT FOR THE DISSERTATION 
Metal Selectivity and Acquisition by the Yersiniabactin Metallophore System in Escherichia coli 
By 
Eun-Ik Koh 
Doctor of Philosophy in Biology and Biomedical Sciences 
Molecular Microbiology and Microbial Pathogenesis 
Washington University in St. Louis, 2016 
Professor Jeffrey P. Henderson, Chair 
 
Urinary tract infections (UTI) are one of the most common bacterial infections, of which, the 
majority are caused by uropathogenic Escherichia coli (UPEC). Many bacterial pathogens 
including UPEC synthesize and secrete chemically diverse metabolites called siderophores, 
which are classically defined by their ability of bind and deliver iron(III), an essential nutrient, to 
pathogens during infections. UPEC isolates can express multiple siderophore systems, of which, 
the virulence-associated siderophore yersiniabactin (Ybt) binds to both iron(III) and copper(II) 
during urinary tract infections. In this thesis we show that Ybt interacts with multiple physiologic 
transition metals and acts as a metallophore system to deliver select metal ions to UPEC. We 
show Ybt transporters promote bacterial fitness during urinary tract infections, consistent with a 
pathogenic gain-of-function conferred by the Ybt system to UPEC.  
 
Direct detection of both iron(III) and copper(II) complexes with Ybt during UTI led to the 
hypotheses that Ybt may interact with additional physiologic transition metals and that these 
complexes are transport substrates for the Ybt import system. Using a mass spectrometry based 
 ix	  
screen, we identified stable trivalent and divalent metal-Ybt complexes that were predicted to use 
similar coordination sites as iron(III)-Ybt. We used bacterial genetic and quantitative mass 
spectrometric approaches to show that these complexes are imported into UPEC by the TonB-
dependent outer membrane transporter FyuA. Of the metal-Ybt complexes examined, copper(II)-
Ybt was predicted to be structurally unique and was the only complex to not competitively 
inhibit iron(III)-Ybt transport. These results suggest that Ybt can preferentially transport iron in 
copper-rich environments where copper(II)-Ybt concentrations may exceed those of iron(III)-
Ybt.  
 
While the Ybt transport system has been shown to be critical for several Gram-negative 
pathogens, its role in UPEC during UTI has been unclear. We used bacterial genetics and 
quantitative mass spectrometric approaches to show that ATP-binding cassette transporters YbtP 
and YbtQ are necessary for iron(III)-Ybt dependent growth but not Ybt synthesis in UPEC. 
Using an experimental murine cystitis model and standard liquid culture conditions, we 
compared the outcome of isogenic wild type and ybtPQ mutant strains and found UPEC lacking 
ybtPQ to exhibit significant competitive fitness defect only during high titer infections. These 
results support a model in which YbtP and Q play an important role in the bladder 
microenvironment during UPEC pathogenesis.     
 
Combining our findings with metal-Ybt import through FyuA and the importance of YbtP and Q 
during UPEC infections, we sought to investigate metal-Ybt import through YbtPQ and the fate 
of intracellular metal-Ybt complexes. Using a combination of bacterial genetics, quantitative 
mass spectrometry and radiolabeling approaches, we observed that in fyuA and ybtPQ-expressing 
 x	  
E. coli, both iron and copper are released from their respective intracellular metal-Ybt complex 
through reduction, with metal-free apo-Ybt recycled to the extracellular medium. This was in 
contrast to intracellular gallium(III)-Ybt, which remained stable with no detectable apo-Ybt 
recycling. These findings are consistent with our model of Ybt as a metallophore system that 
delivers physiologic transition metals to UPEC. The requirements for iron and copper by UPEC 
metalloenzymes may therefore be targets for future investigations and therapeutic development.  
 
Together, the work presented in this thesis describes the Ybt system as a multi-level virulence 
strategy used by UPEC to overcome varying host environments and challenges to metal 
homeostasis.  
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CHAPTER ONE 
Introduction: Microbial copper-binding siderophores at the host-pathogen interface 
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1.1 Siderophores 
Siderophores (Greek for iron carrier) are a diverse group of specialized ferric iron(III)-binding 
metabolites that function to supply iron to the microbe and are the subject of classic works in 
microbial metabolism (1-3). Iron is an essential metal for most bacteria; acting as an essential 
cofactor in diverse physiological processes including respiration, deoxynucleotide biosynthesis, 
and DNA replication (4). The evolution of siderophores is viewed as a response to the 
appearance of O2 in the early atmosphere which resulted in oxidation of soluble ferrous iron 
(Fe(II)) to its relatively insoluble ferric form (Fe(III)) (5).  
 
Siderophores are widely synthesized among microbes, with over 500 different siderophores 
described. These specialized metabolites use a chemically diverse array of metal-binding 
prosthetic groups, often deployed in varying combinations within a single siderophore. Bacterial 
siderophore biosynthesis and transporter proteins are translated when intracellular iron is low, 
classically following transcriptional derepression by the global iron regulator, Fur (ferric uptake 
repressor) (6, 7). Siderophore biosynthetic pathways can be classified as nonribosomal peptide 
synthetase/polyketide synthase (NRPS/PKS) dependent or independent systems. NRPS/PKS are 
large (>350 kD for the yersiniabactin biosynthesis protein irp1 (8)) multienzyme complexes that 
use a wide range of cellular substrates to synthesize various metabolites including catecholate 
and phenolate type siderophores.  
 
Once secreted into the extracellular space, siderophores can bind oxidized metal ions with 
remarkably high affinities (9). Ferric siderophore complexes are subsequently recognized and 
internalized through siderophore-specific transport machinery in bacterial inner and outer 
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membranes. Transport through the Gram-negative outer membrane transporters occurs through 
specialized proteins associated with the TonB protein complex, which transduces energy from 
the cytoplasmic proton motive force (3, 10, 11). Inner membrane ATP-binding cassette 
transporters in both Gram-negative and Gram-positive organisms transport ferric siderophore 
complexes, or the iron released from them, to the cytoplasm (12-16). Once ferric siderophores 
are internalized, their intracellular fate varies between different siderophores, with reported 
examples of Fe(III) reduction to Fe(II) or Fe(III)-siderophore hydrolysis. All or part of the 
siderophore may be recycled and used again after releasing its metal ion cargo (17, 18).   
 
Although pathogens often carry multiple iron acquisition systems that are redundant in 
laboratory culture conditions, siderophore-dependent systems appear to play specialized roles at 
the host-pathogen interface (16, 17, 19, 20). Specifically, siderophores have been ascribed roles 
in liberating ferric ions bound to host iron storage proteins or sequestered away from pathogens 
within distinctive compartments. As such, siderophores have long been considered a microbial 
solution to low iron availability imposed by microenvironments in the infected host (21).  
 
1.2 Uropathogenic E. coli siderophores 
E. coli recovered from infected patients or animals often synthesize different siderophores types 
spanning three chemical families in addition to the prototypical, genetically-conserved 
enterobactin siderophore system (Fig. 1) (22). Although unnecessary for growth in standard 
culture conditions, multiple siderophore genes are upregulated during E. coli urinary tract 
infections (23, 24) and siderophore biosynthesis in this disease has been demonstrated by direct 
mass spectrometric detection (25). The multiplicity of siderophores synthesized by these 
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uropathogenic E. coli strains raises the question of why bacteria would commit scarce cellular 
resources to synthesize chemically distinctive siderophores with a common recognized function 
(26).  
 
One reason pathogenic bacteria may synthesize multiple siderophore types emerged from the 
finding that the inflammation-associated protein siderocalin (SCN, also known as lipocalin 2 
[Lcn2], NGAL, or 24p3) can tightly bind the ferric complex of the prototypical E. coli 
siderophore enterobactin, rendering it’s iron cargo inaccessible to bacteria (27). In contrast, 
functional data with siderophores synthesized from the three genetically non-conserved E. coli 
siderophore systems (salmochelin, yersiniabactin and aerobactin) suggests that these do not bind 
to SCN, leading to their categorization as “stealth siderophores” along with other non-E. coli 
siderophores with this property. SCN-deficient mice exhibit increased susceptibility to 
bloodstream infections with E. coli that produce enterobactin as its sole siderophore, consistent 
with a physiologic role for this SCN-enterobactin binding interaction (28, 29). In the human 
urinary environment this situation can be reversed, with enterobactin becoming necessary to 
liberate iron from SCN-bound ferric complexes that form with urinary catechol metabolites (30).  
 
An additional rationale for synthesizing salmochelin (a more polar, glucose conjugated version 
of enterobactin) is suggested by measurements showing that this siderophore partitions into 
cellular membranes less than enterobactin, which may allow it to more effectively scavenge 
ferric ions in membrane rich host environments (31). Finally, using siderophores with different 
pH optima for ferric ion binding may allow uropathogenic E. coli to adapt to a wider range of 
host environments. Aerobactin, for example, may be a better iron scavenger in low pH 
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environments where protonation diminishes the ferric ion affinity of catecholate siderophores 
(32, 33). Together, these findings suggest that siderophores’ remarkable chemical diversity – 
even within a single bacterial strain – may represent chemical co-evolutionary responses to 
numerous selective pressures within vertebrate hosts.  
 
1.3 Cupric yersiniabactin in human infections 
The phenolate/thiazoline-based yersiniabactin (Ybt) siderophore system was first described in 
pathogenic Yersinia species and subsequently found to be the most frequently-expressed, 
genetically non-conserved siderophore system in uropathogenic E. coli (22, 34-36). Ybt is 
synthesized by a large NRPS/PKS complex that has been successfully reconstituted in vitro and 
assembles Ybt through a succession of phosphopantethiene-bound intermediates (37, 38). These 
biosynthetic genes are encoded alongside metabolic, transport, and transcription factor genes in 
the genetically mobile, multi-operon Yersinia High Pathogenicity Island (11, 39).  
 
Although siderophores are known for ferric metal binding, in vitro binding of non-ferric metal 
ions has been widely noted (40-44). To identify the metals that bind Ybt in a biologically 
relevant environment, Chaturvedi et al. devised a liquid chromatography-constant neutral loss 
(LC-CNL) mass spectrometric screen using a yersiniabactin-specific MS/MS fragmentation 
pathway. When Ybt was mixed with pooled urine samples from healthy human donors, LC-CNL 
screen identified a chromatographic peak corresponding to a new metal-yersiniabactin complex. 
Accurate mass values and isotope pattern matched that of a cupric yersiniabactin (Cu(II)-Ybt) 
complex. This complex was replicated using defined components in vitro when Ybt was titrated 
with cupric sulfate solution, producing a visibly blue-colored complex. LC-MS/MS analysis 
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detected Cu(II)-Ybt in urine from urinary tract infection patients infected with yersiniabactin-
producing E. coli, demonstrating the physiologic relevance of copper binding by yersiniabactin. 
Cu(II)-Ybt was also detected in urine and bladder tissue from mice experimentally infected with 
UTI89, a model yersiniabactin-producing uropathogenic E. coli strain. Interestingly, the Cu(II)-
Ybt/Fe(III)-Ybt molar ratio in both human and mouse specimens was consistently greater than 1, 
suggesting that Ybt binds host-derived copper at least as extensively as Fe(III) during infections 
(25).  
 
These findings provide direct mass spectrometric evidence that yersiniabactin is produced during 
human urinary tract infections and that metal availability and yersiniabactin metal affinities are 
such that copper complexes exceed iron complexes. The observed excess copper complexes may 
reflect host responses that limit siderophore-accessible iron (nutritional immunity) as well as 
inflammation-associated processes that increase copper availability at the host-pathogen 
interface (19, 45, 46). The presence of a virulence-associated, copper-binding siderophore in E. 
coli may reflect an adaptive response to the distinctive physiologic metal composition that arises 
in infection microenvironments (21). Yersiniabactin may play a similar role in Yersinia pestis, 
where it is linked to virulence in experimental animal models (12, 47). Common structural 
features of yersiniabactin and other biological copper-binding molecules may facilitate 
identification of analogous biological copper carriers in other microbial pathogens.  
 
1.4 Structural features of biological copper-binding molecules 
Although yersiniabactin is currently the best-described example of a siderophore shown to bind 
copper in the host, other examples may await discovery. Structural features of well-known 
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extracellular copper carriers may assist identification of currently unappreciated copper binders 
among pathogen-associated siderophores. In the mammalian host, the prototypical extracellular 
copper carrier is ceruloplasmin, which carries up to 95% of circulating copper and rises and falls 
with copper excess and deficiency, respectively (48). A ~2kD urinary copper-binding molecule 
has also been observed in copper-overloaded mice but has not been structurally characterized 
(49). Copper ions bound to ceruloplasmin are critical components of its multicopper oxidase 
function, which is essential for normal mammalian iron homeostasis. Ceruloplasmin harbors 6 
copper atoms in three distinct copper sites as is typical of the conserved multicopper oxidase 
family (50). Ceruloplasmin contains three type I “blue copper” sites, two of which coordinate a 
single copper ion using a cysteine residue, a methionine residue and two histidine residues (Fig. 
2a). The other three copper ions form a histidine-rich trinuclear copper cluster in which four 
histidine imidazole nitrogens coordinate one Type II copper and three histidine residues 
coordinate two Type III copper ions (51). These six copper atoms are required to achieve the 
final conformation-driven state, and are incorporated during ceruloplasmin biosynthesis late in 
the secretory pathway (52). Although an array of negatively charged groups might effectively 
coordinate copper, it is notably that cuproproteins often use histidine imidazole nitrogens for this 
purpose. Indeed this is a useful basis for identifying new cuproproteins from genomic databases 
(53, 54). Incorporation of analogous nitrogen-containing heterocycles into protein and non-
protein microbial products may confer a similar copper binding preference.  
 
Among prokaryotes, a new family of copper binding, siderophore-like, natural products has 
recently been described among methanotrophic Gram-negative bacteria from environmental 
sources. Methanobactins (Mb) are a family of small molecules secreted into the extracellular 
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space to scavenge copper for nutritional purposes (for detailed review, see (42)). These 
chalkophores (Greek for copper carriers) help satisfy the high copper demand resulting from 
biosynthesis of particulate methane monooxygenase, which permits methanotrophs to use 
methane as their sole carbon source (55, 56). There are numerous similarities between Mb and 
Gram-negative bacterial siderophores systems. Gram-negative siderophores and Mb are actively 
transported through the outer membrane by TonB-dependent transporters, and possess distinctive 
heterocyclic structural elements involved in metal binding (43, 57). As in most cuproproteins, 
biophysical studies of Mb implicate heterocyclic nitrogens (oxazolones for Mb) in copper ion 
coordination (Fig. 2b). Use of these chemical groups to bind copper in Mb raise the possibility 
that previously-described mechanisms for nitrogen heterocycle incorporation into other peptides 
and natural products (reviewed by Walsh et al. (58)) may facilitate copper binding in some of 
these molecules.  
 
Yersiniabactin is a nonribosomal peptide synthase/polyketide synthase (NRPS/PKS) product that 
lacks the peptide backbone of Mb and possesses three nitrogen-sulfur heterocycles whose 
nitrogens participate in co-planar ferric ion binding identified in crystallographic structures (59, 
60). Quantum mechanical modeling using density functional theory (DFT) predicts similar 
coordination environment for Cu(II)-Ybt, in which the three heterocyclic nitrogens (two 
thiazoline and one thiazolidine) and the phenolate oxygen contribute to a typical square planar 
configuration around Cu(II) (Fig. 2c). However in contrast to other metal-Ybt complexes, Cu(II)-
Ybt is predicted to exist as two closely related linkage isomers with one having an open penta-
coordinate site arising from differential interaction with the terminal carboxylic acid group (61, 
62). A similar phenolate-thiazoline role in copper-binding may occur with pyochelin, a related 
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siderophore from the opportunistic pathogen Pseudomonas aeruginosa, in which UV/visible 
analysis indicates formation of an in vitro Cu(II) complex (41). The consistent appearance of 
nitrogen-containing heterocycles in ceruloplasmin, methanobactin, and yersiniabactin metal-
binding sites suggests a particularly important role for this structural element in binding copper. 
More examples of copper-binding molecules are necessary to properly evaluate this association 
and to predict biologically meaningful copper binding activity among microbial siderophores.  
 
1.5 Copper-binding siderophores as a defense against host-derived copper toxicity 
Secreted copper-binding molecules may have evolved in pathogens to neutralize the antibacterial 
activity of copper (for recent reviews, see (46, 63, 64)). While inflammatory responses 
classically limit transition metal bioavailability, copper appears to be a notable exception. 
Several works report unchanged or increased systemic and local copper availability during 
infections (65-68).  More recently, White et al., have shown ATP7A-mediated copper trafficking 
from the Golgi apparatus to E. coli-containing phagosomes, consistent with a bactericidal system 
that targets phagocytosed microorganisms (45). Within this restricted phagosomal space, 
(~1.2×10-15 L (69)) toxic levels of copper sufficient to kill microbes may be rapidly achieved.  
 
Consistent with an important role for copper-based host defenses, uropathogenic E. coli isolates 
have been observed to exhibit greater copper resistance than intestinal isolates in urinary tract 
infection patients. Yersiniabactin synthesis was associated with copper resistance in these 
isolates and a causative association was supported by a significant decrease in resistance by 
yersiniabactin-null mutants and a significant increase in resistance following supplementation 
with purified yersiniabactin (25). A similar relationship was observed in Pseudomonas 
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aeruginosa, where synthesis of the virulence-associated siderophores pyochelin and pyoverdine 
(70, 71) increased copper resistance (72). Furthermore Pseudomonas aeruginosa with deficiency 
in copper detoxification system showed reduced virulence, though connections with pyochelin 
and pyoverdine were unexplored (73). Further studies will be necessary to examine how Cu(I) in 
the phagosome is oxidized to Cu(II) for yersiniabactin binding. The bacterial periplasmic multi-
copper oxidase, CueO, has been suggested to oxidize Cu(I) to Cu(II) (74, 75). These copper 
defense systems may thus work in tandem with yersiniabactin and related siderophores to 
sequester Cu(II) ions.  
 
Not all siderophores protect against copper toxicity. Catecholate siderophores in E. coli 
sensitized them to copper toxicity, an effect linked to Cu(II) reduction by catechols to the more 
cytotoxic Cu(I) ion (25, 74, 76). When bound to yersiniabactin, catechols were unable to reduce 
Cu(II) (25). In the presence of copper ions, yersiniabactin may thus protect E. coli by preventing 
enterobactin-mediated Cu(I) formation (Fig. 3). It is however unclear whether aerobactin is 
similarly involved in strains that produce this siderophore.  
 
The mechanism of copper toxicity in bacteria is incompletely understood. Cu(I) toxicity through 
Fenton reaction-mediated hydroxyl radical (OH) generation has long been proposed to be an 
important mechanism, although observations that copper-loaded E. coli are more – not less –   
resistant to hydrogen peroxide suggests that Fenton chemistry alone is an inadequate explanation 
(77). Recent works instead point to a major role for cytoplasmic Cu(I) in dissociating iron-sulfur 
clusters and thereby interfering with multiple metabolic processes including heme and branched 
chain amino biosynthesis (78-80). This mechanism finds additional support from the finding that 
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metal ions that do not act as Fenton reagents but also disrupt iron-sulfur clusters exert similar 
toxicity (81, 82). While further studies are needed to dissect the toxic activities of copper, these 
results point to the ability of yersiniabactin to prevent free copper from reaching the cytoplasm 
as an important virulence function.  
 
A pathogenic role for yersiniabactin copper binding was assessed in a version of the macrophage 
survival assay first described by White et al. (45). In this study, a yersiniabactin-deficient 
uropathogenic E. coli was profoundly sensitized to intracellular killing by macrophage-like 
RAW264.7 cells relative to its yersiniabactin-proficient isogenic wild type control (61). The 
yersiniabactin-null phenotype was abolished when copper-deficient RAW264.7 cells were used. 
This sensitization phenotype was similar to that observed for a K12 E. coli strain lacking the 
copper efflux pump CopA (83). Overall, these results are consistent with yersiniabactin 
sequestration of phagosomal copper ions as a contributor to intracellular survival. Together, 
these findings support a role for non-reducing, copper-binding siderophores in protecting 
pathogens from copper-based host defenses.  
  
1.6 Copper-binding siderophores as a countermeasure against superoxide-based host 
defenses 
Phagocytes are a classic host defense against invading microbial pathogens and the copper-
dependent ATP7A bactericidal system described by White et al. is one of several chemical 
defenses deployed by these cells (45). Also notable among these defenses is the “respiratory 
burst”, in which a membrane-bound NADPH oxidase generates superoxide anion (O2-) within 
the phagosome (84).  
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Yersiniabactin synthesis was implicated in resisting superoxide-dependent host defenses through 
the observation that the yersiniabactin-dependent intracellular survival phenotype requires both 
copper and NADPH oxidase activity (61). Subsequent studies identified a soluble superoxide 
dismutase-like activity in UPEC-conditioned media that was similarly dependent upon 
yersiniabactin biosynthesis and copper supplementation. Chromatographic fractionation and 
mass spectrometric analysis associated this soluble SOD-like activity to Cu(II)-Ybt. Purified 
Cu(II)-Ybt exhibited SOD-like activity that was also observed upon substitution of Cu(II) with 
Fe(III) but not with non-redox active gallium (III), consistent with a catalytic requirement for 
redox active metal. Unlike previously-described cupric salicylate complexes with SOD-like 
activity, Cu(II)-Ybt retained its activity in the presence of protein, which acts as a competitive 
copper chelator (61). These data are consistent with the ability of non-protein Cu(II)-Ybt 
complexes to catalyze superoxide dismutation as follows: 
 
Cu(II)-Ybt + O2- à Cu(I)-Ybt + O2 
Cu(I)-Ybt + O2- +2H+ à Cu(II)-Ybt + H2O2 
 
Density functional theory-based quantum simulations of this catalytic cycle supported a key role 
for copper redox cycling during coordination by the phenolate, thiazoline, and thiazolidine 
groups in yersiniabactin (61). There is evidence that the thiolate and heteroaromatic ring 
coordination sites of methanobactin may support a similar catalytic cycle (85). Although the 
catalytic activity of Cu(II)-Ybt does not exceed that of periplasmic Cu, Zn-SOD, the 
extracellular localization of yersiniabactin would be expected to place it in closer proximity to 
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the superoxide source (the host NADPH oxidase complex) where it may be more effective. 
Cu(II)-Ybt catalysis may further benefit the pathogen through its lower metabolic cost of 
production and its likely ability to avoid proteolysis, which may permit substantial accumulation 
within the phagosome. Siderophore-based catalysts that take advantage of host-supplied copper 
may therefore be well-suited to this distinctive host environment (86) (Fig. 3).  
 
An analogous protective role for an extracellular copper-binding protein was recently suggested 
by Gleason et al., in the human fungal pathogen Candida albicans (87). Candidal SOD5 was 
found to possess an open active site that readily captures extracellular copper for its activity. 
Although it lacks the zinc-binding site, it is otherwise structurally homologous to Cu, Zn-SODs 
and rapidly reacts with superoxide with rates approaching the dismutase limit (87). 
Yersiniabactin and SOD5 may thus use similar strategies to catalyze superoxide dismutation 
through spontaneous capture and immobilization of host-supplied, extracellular copper. A more 
detailed investigation of copper-based dismutation catalysts in this context will require an 
improved biochemical understanding of the role of superoxide in microbial killing. Nevertheless, 
it appears likely that additional examples of this survival strategy await discovery among 
invasive, disease-associated microorganisms.  
 
The surprising ability of yersiniabactin production to modulate copper-dependent intracellular 
survival underscores that there is still much to learn about transition metal interactions at the 
host-pathogen interface. As the phagosome matures, metal content, pH, and redox potential may 
change dramatically (for recent reviews, see (88, 89)). Future measurements of the binding 
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affinity of yersiniabactin for Cu(II) and Cu(I), both of which may be present within the 
phagosome, would aid these investigations.  
 
1.7 Questions and hypotheses 
While Ybt’s interactions with copper has largely focused on its extracellular protective roles, the 
role of Ybt in delivering copper to pathogens has been unclear. Methanobactin is a notable 
precedent for a siderophore-like small molecule that scavenges and delivers copper (a 
chalkophore) to bacteria. While methanotrophic Gram-negative bacteria use methanobactin to 
support exceptional copper demands associated with particulate methane monooxygenase 
biosynthesis (56, 57), it remains unclear whether pathogenic bacteria benefit from a similar 
strategy. Copper is an important cofactor in multiple bacterial enzymes including NADH 
dehydrogenase, cytochrome oxidase and copper, zinc superoxide dismutases (53). Furthermore, 
Gram-negative cuproenzymes such as Cu, Zn-SOD have been described to receive copper in the 
periplasmic compartment (90). Therefore we hypothesized that Ybt may act as a metallophore to 
deliver iron and copper to uropathogenic E. coli. To investigate this hypothesis, this thesis 
examines the following questions: 
 
1. Does Ybt interact with other physiologic metals in addition to iron(III) and copper(II)? 
2. Are non-iron metal-Ybt complexes transport substrates of the Ybt import system? If so, 
what is the fate of intracellular metal-Ybt complexes? 
3. How does the Ybt transport system affect uropathogenic E. coli pathogenesis? 
  
 15	  
CHAPTER ONE: FIGURES 
 
Figure 1. Uropathogenic Escherichia coli siderophores. Pathogenic E. coli isolates synthesize 
multiple siderophore types known to coordinate Fe(III) with a variety of functional groups (22).  
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Figure 2. Extracellular copper binding molecules. a) Ceruloplasmin has six copper-binding 
sites of which three are type I copper centers coordinated with two histidine residues, a cysteine 
residue and a methionine residue (48). b) Methanobactin structures contain a recognizable 
peptide backbone with distinctive oxazolone heterocycles, which are implicated in copper ion 
coordination (43). c) Yersiniabactin has three heterocyclic nitrogens (two thiazoline and one 
thiazolidine) that contribute to a square planar configuration around Cu(II) alongside the 
phenolate oxygen (61).  
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Figure 3. Copper-binding siderophore functions at the host-pathogen interface. Within the 
phagosomal compartments of host phagocytic cells (upper left), yersiniabactin may protect 
bacterial pathogens by sequestering toxic copper ions translocated by ATP7A into the 
phagosome (25,45). The resulting Cu(II)-Ybt complex may further protect the host by catalyzing 
superoxide dismutation to counter superoxide-based host defenses (61). In phagosomal or non-
phagosomal environments characterized instead by copper scarcity, E. coli may import Cu(II)-
Ybt as a nutritional copper source.   
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CHAPTER TWO 
Metal selectivity by the virulence-associated yersiniabactin metallophore system 
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ABSTRACT 
Uropathogenic Escherichia coli secrete siderophores during human infections. Although 
siderophores are classically defined by their ability to bind ferric ions, the virulence-associated 
siderophore yersiniabactin was recently found to bind divalent copper ions during urinary tract 
infections. Here we use a mass spectrometric approach to determine the extent of non-ferric 
metal interactions by yersiniabactin and its TonB-dependent outer membrane importer FyuA. In 
addition to copper, iron and gallium ions, yersiniabactin was also observed to form stable nickel, 
cobalt, and chromium ion complexes. In E. coli, copper(II) and all other non-ferric yersiniabactin 
complexes were imported by FyuA in a TonB-dependent manner. Among metal-yersiniabactin 
complexes, copper(II) yersiniabactin is predicted to be structurally distinctive and was the only 
complex not to competitively inhibit ferric yersiniabactin import. These results are consistent 
with yersiniabactin as part of a metallophore system able to prioritize ferric complex uptake in 
high copper environments.  
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INTRODUCTION 
Numerous bacterial pathogens synthesize and secrete chemically diverse specialized metabolites 
called siderophores, which are defined by their ability to bind ferric iron (Fe(III)) and counter the 
effects of nutritional immunity by the host (1, 2). Most Gram-negative bacteria must first 
actively transport ferric-siderophore complexes to the periplasm through dedicated outer 
membrane transporters powered by the TonB complex, which transduces energy from the 
cytoplasmic proton motive force (3–5). These ferric siderophore complexes, or the iron released 
from them, are subsequently transported to the cytoplasm through inner membrane ATP-binding 
cassette transporters (6–9). 
 
Although only a single siderophore system is necessary for iron-dependent growth in iron-
chelated culture conditions, uropathogenic E. coli (UPEC) isolates can express multiple 
siderophore systems consisting of enterobactin (which is genetically conserved in all E. coli) in 
combination with salmochelin, aerobactin and/or yersiniabactin (10). Among these, the 
yersiniabactin (Ybt) siderophore system is the most frequently-carried, non-conserved 
siderophore system in UPEC (10, 11). Genes encoding Ybt biosynthetic proteins, an outer 
membrane import protein (fyuA), putative inner membrane transporters (ybtP,Q), and a 
transcription factor (ybtA) are present on the non-conserved 30 kilobase multi-operon Yersinia 
High Pathogenicity Island (HPI) (6, 12, 13). Yersinia HPI genes are dramatically upregulated 
during experimental mouse cystitis and Ybt has also been directly detected in the urine of UTI 
patients infected with Ybt-expressing pathogens (14–16). Together these findings are consistent 
with a pathogenic gain-of-function conferred by yersiniabactin siderophore system expression.    
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Recent observations demonstrating that Ybt binds both copper and iron ions during both human 
and experimental animal cystitis suggest that the Ybt system confers a gain-of-function through 
interactions with non-ferric metal ions (16, 17). Chemical diversity among siderophores may 
thus reflect differential “tuning” of these chelators to bind metal ions other than Fe(III), 
including divalent ions such as Cu(II). In intracellular compartments where copper is used as an 
antibacterial agent, Ybt may protect pathogenic bacteria by sequestering copper and catalyzing 
superoxide dismutation (17, 18). To date, it has been unclear whether Cu(II)-Ybt is also an 
additional transport substrate for FyuA, the TonB-dependent outer membrane Fe(III)-Ybt 
importer (4, 6, 19). If non-iron yersiniabactin complexes with physiologic metals are imported, 
yersiniabactin may possess a previously unappreciated metallophore function beyond its classic 
iron scavenging activity.  
 
In this study, we used a liquid chromatography mass spectrometry (LC-MS) based screen to 
unambiguously identify stable Ybt complexes with non-ferric metal ions. We found that Ybt 
forms stable complexes with multiple physiologically relevant trivalent and divalent metal ions 
that are predicted to use similar coordination sites. A combined bacterial genetic and quantitative 
mass spectrometric approach showed that these complexes can be imported into E. coli by the 
TonB-dependent transporter FyuA. Of the non-ferric complexes examined, only Cu(II)-Ybt did 
not competitively inhibit Fe(III)-Ybt uptake. Together these results are consistent with a 
metallophore-like function for the yersiniabactin system that prioritizes iron uptake in copper-
rich intracellular compartments where Cu(II)-Ybt may reach high concentrations. 
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EXPERIMENTAL PROCEDURES 
Bacterial strains, plasmids and culture conditions 
The uropathogenic E. coli isolate UTI89 and the non-uropathogenic K-12 E. coli isolate 
MG1655 were used in this study (20, 21). Strains were grown in LB agar (Becton, Dickson and 
Company), LB broth (Becton, Dickson and Company), YESCA (Yeast extract-Casamino acids) 
broth or M63 minimal media (10) with antibiotics as appropriate. Ampicillin (100 µg/mL, 
Goldbio), kanamycin (50 µ/mL, Goldbio) were used for plasmid selection. In-frame deletions in 
UTI89 and MG1655 were made using the standard red recombinase method, using pKD4 or 
pKD13 as a template (22). Deletions were confirmed using PCR with flanking primers. 
Antibiotic resistance insertions were removed by transforming the strains with pCP20 expressing 
the FLP recombinase. Plasmids were made using the pTrc99a vector (23) and cloning in genes 
using standard PCR and recombination techniques.  
 
Yersiniabactin and 13C-Yersiniabactin preparation  
Apo-Ybt was generated from UTI89ΔentB grown in M63 minimal medium supplemented with 
0.2% glycerol (v/v) and 10mg/ml niacin (Sigma) as previously described (16). 13C-Ybt was 
produced by growing the UTI89Δfur strain in media supplemented with 13C-labeled glycerol as 
previously described (16). Metal-Ybt complexes were generated by adding metals salts to culture 
supernatant to a final concentration of 10mM. The metal salts added were iron(III) chloride, 
copper(II) sulfate, nickel(II) nitrate, cobalt(II) chloride, chromium(II) chloride, gallium(III) 
nitrate, zinc(II) sulfate or manganese(II) chloride (Sigma), respectively. Metal-treated 
supernatants were incubated for 2 hours at 4 degrees and then applied to a methanol conditioned 
C18 silica column (Sigma). Samples were eluted with 80% methanol. Lyophilizer was used to 
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concentrate the eluate overnight. Dried samples were resuspended in 20% methanol and further 
purified through high-performance liquid chromatography using C18 silica column (Whatman 
Partisil). The following gradient was used: Solvent A (0.1% (v/v) formic acid) was held constant 
at 80%, and solvent B (100% (v/v) acetonitrile in 0.1% formic acid (v/v)) was held constant at 
20% for 2 min, then solvent B was increased to 100% by 20 min. Metal-Ybt containing fractions 
were collected, dried down using a lyophilizer and resuspended in deionized water. Isotope 
labeled metal-Ybt complexes were confirmed by LC-MS at corresponding masses. 
 
Complex validation by ICP-MS  
HPLC-purified metal-Ybt complexes were dried down using a lyophilizer and resuspended in 
ultrapure water and trace metal grade nitric acid (Fisher). Final concentration of nitric acid was 
2% v/v. Samples were diluted 1:10 using 2% nitric acid solution, and metal concentrations were 
analyzed by high resolution ICP-MS (Agilent 7500 ICP-MS). Machine was calibrated using 
Environmental calibration standard (Agilent) and PerkinElmer Pure Plus ICP-MS standard 
(PerkinElmer).  
 
Yersiniabactin complex preparations  
Absorption spectra were measured using a quartz cuvette on a standard UV/Vis spectrometer 
(Beckman Coulter DU800). The Fe(III)-Ybt absorption spectra local maximum observed at 385 
nm matched the previously reported local maximum (24). Extinction coefficients using Beer’s 
law for each Ybt complex were determined using their distinctive local absorption maxima 
(Table 1) relative to absolute concentration determined by ICP-MS assuming the observed 1:1 
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(metal:Ybt) stoichiometry.  These extinction coefficient values were used to determine metal-Ybt 
complex concentrations. 
 
Liquid chromatography-mass spectrometry 
LC-MS analyses were conducted using a Shimadzu UFLC-equipped AB-Sciex 4000 QTrap 
operated in positive ion mode using the Turbo V ESI ion source and a Thermo LCQ Deca as 
previously described (16). The samples were injected onto a Fused-core phenylhexyl column 
(100 × 2 mm, 2.7-µm particle, Ascentis Express, Supelco) with a flow rate of 0.4 ml per min. 
The following gradient was used: Solvent A (0.1% (v/v) formic acid) was held constant at 98%, 
and solvent B (90% (v/v) acetonitrile in 0.1% formic acid (v/v)) was held constant at 2% for 2 
min, then solvent B was increased to 65% by 10 min and then to 98% by 12 min. The ion spray 
voltage was set to 5 kV. The heater temperature was 500 °C. The declustering potential, 
nebulizer gas (G1), auxiliary gas (G2) and collision energy were set at 110V, 40V, 35V and 35V, 
respectively. 
 
Liquid chromatography-constant neutral loss analysis  
The UFLC-4000 QTrap was used with settings described above to identify compounds with a 
common neutral fragment loss of 187 m/z units as shown previously (16). The collision energy 
was set to 35 V, and the first mass analyzer (Q1) was set to scan from m/z 200 to 800 a.m.u., 
whereas the second mass analyzer (Q3) simultaneously scanned at 187 m/z units less than Q1. To 
identify 13C-labeled metal-Ybt samples, settings were changed to scan for 195-a.m.u. neutral 
loss. 
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Theoretical calculations  
Theoretical calculations were conducted in collaboration with Dr. Daryl Giblin at the 
Department of Chemistry at Washington University in St. Louis. Theoretical calculations were 
performed to characterize the potential-energy surface (PES) associated with fragmentation and 
reaction as previously described (17). Conformer spaces for precursors (cupric and ferric 
complexes with Ybt), and intermediates were explored by Monte Carlo/MMFF molecular 
mechanisms/dynamics methods. From these results, structures of precursors, intermediates, and 
scans for associated transition states were explored by using the PM3 semi-empirical algorithm 
(25), both in Spartan (26), for Linux v. Two (Wave function, Inc.). DFT (Density Functional 
Theory, part of Gaussian 03 and 09 suites, Gaussian Inc.) calculations were performed by using 
the PBE0 functional (27, 28) (PBE1PBE in Gaussian parlance) with basis sets Def2-SVP and 
Def2-TZVP (29). Minima and transition states were optimized at the level PBE1PBE/Def2-SVP 
and confirmed by vibrational frequency analysis. In addition, connections of transition states to 
minima were examined by inspection, projections along normal reaction coordinates, and path 
calculations as necessary. Single-point energies were calculated at level PBE1PBE/Def2-TZVP, 
and scaled thermal-energy corrections were applied using scaling factors for B3LYP/6-31G(d,p) 
(30). Solvent-based single-point energies were calculated at the same level by using the CPCM 
polarizable conductor calculation model for water and using the Universal Force Field for atomic 
radii (31).  The hybrid functional and basis sets were chosen on basis of performance with 
transition metal complexes (32, 33). DFT was selected for high-level calculations on pragmatic 
reasons because it requires overall less computational overhead than ab initio methods and 
performs adequately (34–36). All results are reported in kcal/mol as enthalpies of formation 
relative to a selected, suitable precursor. 
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Yersiniabactin neutral has 4 labile protons and 12 Lewis base sites: 3N, 3S, 4O, and 2 classes of 
positions on the terminal salicylate moiety. The N, S, and O atoms are potential complexation 
sites with the metal ion. Yersiniabactin can interact with the metal ions using combinations of the 
Lewis base sites and variable coordination numbers to the metal. We chose as starting geometry 
for the ferric complex that based on the crystal structure: hexacoordinate octahedral involving 
complexion with 3N and 3O (37) with high-spin Fe(III), S=5/2. Starting with yersiniabactin 
having the protons of the three hydroxyl moieties removed and complexed with ferric ion, we 
added sequentially protons, optimized, and determined enthalpies to which was added the next 
proton to that state of the complex and procedure repeated until the singly-charged positive-ion 
state was achieved.  For other metal complexes, we substituted the metal cations for ferric, 
optimized geometries similarly, and determined optimum molecular-orbital spin state. For the 
other metals: Cu(II), S=1/2; Co(III), S=0: Ga(III), S=0, Ni(II), S=1, Cr(III), S=3/2.  
 
Fe(III)-Ybt dependent growth  
Following overnight growth in YESCA media, strains were normalized for starting OD600 in 
YESCA with 2mM EDDHA (Complete Green Company) and grown for 1 hour in 37 degrees 
while shaking. 1µM HPLC-purified Fe(III)-Ybt was added to strains and grown for 9 hours in 37 
degrees while shaking. Bacterial growth was measured using OD600 readings as well as viable 
colony forming unit (CFU) measurements. Fold increase in growth was determined by 
calculating the ratio of CFU at end point over start point for every strain examined.  
 
Cell-associated metal-Ybt  
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Following overnight growth in YESCA media, strains were diluted to OD600 of 0.8 in YESCA. 
HPLC-purified metal-Ybt was added to strains and grown for 30 minutes in 37 degrees while 
shaking. In case of multiple metal-Ybt complexes, metal-Ybt mixture in a cell-free control was 
conducted to check for changes in relative metal-Ybt ratios. Bacteria were pelleted at 7500 g for 
10 minutes (Eppendorf) and washed with 1X PBS (Sigma). Bacteria were resupsended in 100% 
ethanol (Sigma) and pelleted at 20000 g for 10 minutes (Eppendorf). Supernatant was collected 
and dried overnight using a vacuum concentrator. Samples were resuspended in ultrapure water 
and applied to a conditioned C18 silica column with added 13C-labled Fe(III)-Ybt internal 
standard. Metal-Ybt quantification was carried out in the multiple reaction monitoring mode 
using known collision-induced dissociation fragmentations and 13C-labeled Fe(III)-Ybt internal 
standards.  
 
Statistical Analyses  
Statistics and graphs were generated using GraphPad Prism 5 (GraphPad software). Student’s t-
test was used to compare growth differences and cell-associated metal-Ybt levels between paired 
strains.  
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RESULTS 
Mass spectrometric screen for stable metal-Ybt complexes 
To identify stable metal-Ybt complexes, we used a previously described mass spectrometric 
screen (liquid chromatography-constant neutral loss; LC-CNL) to detect metal-Ybt complexes in 
aqueous solutions containing apo-Ybt at pH 7 and metal salts in molar excess (10mM final 
concentration) (16). We selected transition metal species with known physiologic roles such as 
zinc(II), manganese(II), nickel(II) and cobalt(II) (2), and chromium(II). The established Ybt 
ligands iron(III), copper(II), and gallium(III) served as positive controls. LC-CNL ion 
chromatograms from Ybt solutions containing chromium, cobalt and nickel revealed new peaks 
with mass spectra and retention times that differ from apo-Ybt or other known metal-Ybt 
complexes. No new peaks were observed from Ybt solutions containing zinc and manganese (Fig 
1). When HPLC was performed without acid modifier to avoid possible acidic dissociation of 
complexes, no new peaks corresponding to zinc or manganese complexes were observed (data 
not shown). A molar excess of Zn(II) furthermore did not alter 0.1 µM apo-Ybt and Fe(III)-Ybt 
peaks areas (Supplementary Fig 1). Detection of chromium, cobalt and nickel-Ybt complexes 
suggest a broader range of Ybt ligands beyond the previously identified Fe(III), Cu(II) and 
Ga(III) ions. While these results do not rule out the existence of Ybt complexes with zinc or 
manganese, isolated complexes with these metals may not be sufficiently stable or sensitive to be 
detected under these conditions. 
 
To obtain more detailed structural information about the new products observed in the LC-CNL 
screen, we subjected the new peaks from chromium, cobalt and nickel-containing Ybt samples to 
MS and MS/MS analyses. The chromium-Ybt mass spectrum showed a dominant peak at m/z 
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531 and prominent M-2 and M+1 peaks at m/z 529 and 532 respectively. These are 49 a.m.u. 
higher than the Ybt [M+H]+ ion with M-2 and M+1 isotopes, consistent with a singly charged 
chromium complex of the form [Ybt-2H + Cr(III)]+. The mass spectrum isotope distribution was 
consistent with the natural abundance of 50Cr, 52Cr and 53Cr isotopes at 4%, 84% and 10% 
respectively (Fig 2A). MS/MS fragmentation of the monoisotopic peak at m/z 531 revealed a 
prominent 187 a.m.u. neutral loss alongside other fragments. One such fragment was a 46-a.m.u. 
neutral loss, which is consistent with a thioformaldehyde loss (Fig 2D), from the thiazoline ring 
bearing the terminal carboxylic acid. The cobalt-Ybt mass spectrum revealed a base peak at m/z 
538 without additional prominent isotope peaks. At 56 a.m.u. higher than the Ybt [M+H]+ ion, 
this ion was consistent with a singly charged cobalt complex of the form [Ybt-2H + Co(III)]+ 
(Fig 2B). The lack of a prominent isotope peak was consistent with cobalt, whose only stable 
isotope is 59Co. MS/MS analysis of the monoisotopic peak at m/z 538 revealed a fragmentation 
pattern with a 187-a.m.u. neutral loss as well as other fragments, including  a 44-a.m.u. neutral 
loss consistent with loss of CO2 from the terminal carboxyl group (Fig 2E). Ambient oxidizing 
conditions together with possible stabilization of the trivalent forms by Ybt likely contributed to 
trivalent cobalt and chromium complex formation despite their addition as divalent salts. Nickel-
Ybt mass spectrum also features a dominant peak at m/z 538 but also exhibits a prominent M+2 
peak at m/z 540. At 56 a.m.u. higher than the Ybt [M+H]+ ion with a prominent M+2 isotope, 
this is consistent with a singly charged nickel complex of the form [Ybt-H + Ni(II)]+. The 
observed isotope pattern matches the natural 58Ni and 60Ni abundances of 68% and 26% 
respectively (Fig 2C). The monoisotopic m/z 538 peak MS/MS spectrum was dominated by a 
187 a.m.u. neutral loss (Fig 2F).  
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Additional compositional information was achieved by stable isotope labeling and ICP-MS. 13C-
isotope labeling shifted all new products 21 m/z units higher than unlabeled complexes, 
consistent with yersiniabactin’s 21 carbon atoms (16). Subsequent MS/MS analysis revealed a 
shifted dominant MS/MS neutral loss of 195 mass units, corresponding to loss of a fragment 
containing eight carbons (Supplementary Fig 2). All metal-Ybt complexes identified above were 
stable following chromatographic purification on the basis of LC-MS and UV/visible absorption 
profiles. We further validated metal-Ybt complex identifications using ICP-MS to measure the 
dominant metal species in HPLC-purified specimens. Through ICP-MS analysis, we found that 
the metal ion corresponding to the metal-Ybt sample was the dominant metal ion. Together, 
these data support Ybt’s ability to bind and form stable metal complexes with Fe(III), Cu(II), 
Cr(III), Ga(III), Co(III), and Ni(II). 
 
Theoretical structural modeling supports a distinctive Cu(II)-Ybt structure 
To address the physical plausibility of new yersiniabactin complexes we used a quantum-based 
density function theory (DFT) approach (17) to simulate each complex in both the gas-phase 
(mass spectrometer) and in solution (H2O). We validated this approach by comparing the 
calculated neutral Fe(III)-Ybt complex structure to the experimentally-determined Fe(III)-Ybt X-
ray crystal structure (37). Both structures were virtually identical, supporting the validity of the 
DFT approach (Supplementary Fig 3). We then simulated the stable metal-Ybt complexes 
observed in the mass spectrometer: Cu(II)-, Co(III)-, Ni(II)-, Fe(III)-, Cr(III)-, and Ga(III)-Ybt.  
All complexes are predicted to share a common square planar core involving the salicylate 
oxygen and the three nitrogens of yersiniabactin. Although thioethers have been shown to 
interact with copper ions in some proteins (through methionine (38)), forcing these interactions 
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in DFT simulations eliminated the nitrogen interactions and led to markedly less stable isomers. 
With the notable exception of Cu(II)-Ybt, all other complexes were predicted to share the hexa-
coordinate octahedral configuration previously observed for Fe(III)-Ybt (37). Cu(II)-Ybt is 
distinguished by two elongated axial ligand bonds to the aliphatic alcohol and terminal carboxyl 
groups. Cu(II)-Ybt has a second energetically competitive form that lacks the axial cupric to 
carbonyl bond (Fig 3) rendering that form penta-coordinate with an open coordination site.  
 
The MS/MS fragmentation data is consistent with the calculated gas phase structures (relevant to 
MS experimental conditions) for each complex. Gas phase structures vary for M(III)-Ybt mono-
positive complexes, which were calculated to have the charging proton on the terminal carbonyl 
oxygen of the axial carboxylate ligand rather than the secondary alcohol. Overall, the calculated 
structures agree with the available experimental data. All the chromatographically isolated metal 
yersiniabactin complexes observed here are predicted to be stable by DFT simulation. Among 
these complexes, Cu(II)-Ybt is predicted to be the most structurally and electronically 
distinctive.  
 
FyuA and YbtPQ are required for Fe(III)-Ybt dependent growth in UPEC 
To confirm the role of UPEC-encoded FyuA and YbtPQ in E. coli Fe(III)-Ybt utilization, we 
measured growth of the model UPEC strain UTI89 and the Yersinia HPI-null K12 strain 
MG1655 with purified Fe(III)-Ybt as the sole iron source in otherwise nutrient-rich media. E. 
coli strains were grown in nutrient-rich YESCA (yeast extract-casamino acids) media containing 
1 µM purified Fe(III)-Ybt and the iron chelator EDDHA, which sequesters non-siderophore-
bound Fe(III). Wild type UTI89 growth exceeded that of UTI89ΔfyuA and UTI89ΔybtPQ in the 
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presence (Fig 4A), but not absence (Fig 4B) of Fe(III)-Ybt. Plasmid-complemented UTI89ΔfyuA 
and UTI89ΔybtPQ showed restored growth to wild type UTI89 levels (Supplementary Fig 4). In 
the Yersinia HPI-null MG1655 strain background, which lacks yersiniabactin transport genes, 
Fe(III)-Ybt-dependent growth required simultaneous ectopic expression of FyuA and YbtPQ 
(Fig 4C, D). These results show that FyuA and YbtPQ are sufficient for Fe(III)-Ybt-dependent 
growth in both UPEC and K12 E. coli. The inability of FyuA alone to promote Fe(III)-Ybt-
dependent growth in MG1655 is consistent with the current model in which FyuA delivers 
Fe(III)-Ybt to the periplasmic, not cytoplasmic space.   
 
FyuA imports intact Fe(III)-Ybt complexes in a TonB-dependent manner 
To determine whether E. coli use FyuA to import Fe(III)-Ybt complexes, we used stable isotope 
dilution mass spectrometry (LC-MS/MS) to directly localize exogenously-supplied metal-
yersiniabactin complexes. With this approach, Fe(III)-Ybt could be quantified in UTI89 cell 
extracts following a 30 minute exposure to 0.1 µM purified Fe(III)-Ybt (Fig 5A, B). These cell-
associated Fe(III)-Ybt levels were nearly eliminated in UTI89ΔfyuA and were restored by 
genetic complementation in UTI89ΔfyuA pfyuA. This complementing plasmid further conferred 
robust cellular Fe(III)-Ybt localization in MG1655 (Fig 5C). Because Fe(III)-Ybt can form a 
stable FyuA-bound complex (19), we examined localization in MG1655ΔtonB background, 
which lacks the energy transduction system required for active transport to the periplasm. Cell-
associated Fe(III)-Ybt was significantly lower in MG1655ΔtonB pfyuA than in MG1655 pfyuA. 
Furthermore, cell-associated Fe(III)-Ybt in MG1655ΔtonB pfyuA lacked the dose-dependent 
relationship observed in MG1655 pfyuA (Fig 5D). Overall, these observations support the model 
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in which FyuA is sufficient to transport intact Fe(III)-Ybt through the Gram negative outer 
membrane in a TonB-dependent manner.  
 
FyuA imports Cu(II)-Ybt and other non-ferric complexes in a TonB-dependent manner 
To determine whether E. coli can use FyuA to import non-iron Ybt complexes, we used LC-
MS/MS to directly localize exogenously-supplied yersiniabactin complexes. With this approach, 
non-iron Ybt complexes could be quantified in bacterial cell extracts following a 30-minute 
exposure to 0.1 µM purified metal-Ybt (Fig 6, left). These cell-associated metal-Ybt levels were 
nearly absent in wild type MG1655 while MG1655 pfyuA conferred robust cellular metal-Ybt 
localization at similar molar quantities (Fig 6, left). To investigate non-iron Ybt interactions with 
FyuA, we examined localization in MG1655ΔtonB pfyuA. Cell-associated Ybt complexes were 
significantly lower in MG1655ΔtonB pfyuA than in MG1655 pfyuA. Furthermore, cell-associated 
metal-Ybt in MG1655ΔtonB pfyuA lacked the dose-dependent relationship observed in MG1655 
pfyuA (Fig 6, right). Interestingly, we found cell-associated Cu(II)-, Ga(III)-, Co(III)- and Ni(II)-
Ybt levels rise and then decrease in MG1655 pfyuA with increasing metal-Ybt concentrations in 
the media (Fig 6, right). These distinctive transport features at higher concentrations may reflect 
higher order interactions with FyuA or variable intracellular metal-Ybt instability. Overall, these 
observations support a model in which FyuA imports non-iron Ybt complexes through TonB-
mediated active transport. While this was expected for Ga(III), a classic non-physiologic ferric 
ion mimic, import of physiologically relevant metals raises the possibility that these are imported 
by FyuA during infections. 
  
Cu(II)-Ybt does not competitively inhibit Fe(III)-Ybt uptake  
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The specific molecular sequence of events by which FyuA imports yersiniabactin complexes is 
incompletely understood. To determine whether ferric and non-ferric-Ybt complexes are 
imported through a similar pathway and whether Fe(III)-Ybt is a preferred substrate, we 
measured import by MG1655 pfyuA exposed to both complexes under competitive conditions. 
Ectopic expression in MG1655 allows consistent FyuA expression for all experimental 
conditions, whereas native FyuA expression in UTI89 is subject to an incompletely understood 
regulatory network for yersiniabactin genes (12). In this experimental system, increasing Fe(III)-
Ybt concentrations in media containing 0.1 µM of each non-ferric-Ybt complex inhibited non-
metal Ybt complex import (Fig 7, left) in the order Ni(II)~Cr(III) >  Cu(II)~Co(III) > Ga(III). 
This is consistent with competitive inhibition of non-ferric yersiniabactin complex uptake by 
Fe(III)-Ybt, again suggesting a common uptake mechanism for all metal-yersiniabactin 
complexes.  
 
When Fe(III)-Ybt was instead held constant at 0.1 µM and non-ferric-Ybt concentrations 
increased, all non-ferric-Ybt complexes with the notable exception of Cu(II)-Ybt competitively 
inhibited Fe(III)-Ybt import. Of note, while Ni(II)-Ybt inhibited Fe(III)-Ybt transport, cellular 
Ni(II)-Ybt levels remained low (Fig 7, right). Overall, Cu(II)-Ybt exhibited the most distinctive 
dose-response relationship, with diminished cell-associated Cu(II)-Ybt at higher concentrations 
and no discernable ability to inhibit Fe(III)-Ybt uptake. Distinctive transport properties of Cu(II)-
Ybt may reflect contributions from differential FyuA binding, transport rate, and/or periplasmic 
dissociation. While the physiologically relevant Cu(II)-Ybt concentration range is unknown, 
Cu(II)-Ybt may reach high levels in the intracellular compartments of mammalian cells (18), 
making FyuA’s ability to sustain import of scarce Fe(III)-Ybt a possible adaptation to this 
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environment. This ability may reflect an interaction between FyuA and the distinctive Cu(II)-Ybt 
structure predicted above (Fig 3).  
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DISCUSSION 
This study uses direct mass spectrometric detection to show that Ybt is a promiscuous trivalent 
and divalent metal chelator, forming stable complexes with physiologically relevant metal ions 
Fe(III), Cu(II), Ni(II), Co(III), and Cr(III). FyuA imports each stable Ybt complex in a TonB-
dependent manner in the absence of other Yersinia HPI-encoded proteins. Fe(III)-Ybt 
competitively inhibits non-ferric Ybt uptake, consistent with a shared transport mechanism. 
Cu(II)-Ybt, however, does not competitively inhibit Fe(III)-Ybt import and exhibits maximal 
import at low (0.1 µM) extracellular concentrations.  Together these findings provide new 
evidence for metal-selectivity by the yersiniabactin system (Fig 8) while demonstrating a new 
experimental framework for characterizing siderophore system metal specificity.  
 
Uropathogenic E. coli must adapt to numerous physiologic environments during infection 
pathogenesis. In these environments, the host may deliberately decrease the availability of iron 
and other transition metals to restrict microbial growth (nutritional immunity) and may increase 
copper availability as a microbicidal effector (2, 18, 39, 40). Within an intracellular vesicle such 
as the macrophage phagolysosome, UPEC are confined to a small volume  (~1.2×10-15 L)(41) 
where iron is likely to be scarce while copper ions may be abundant. Yersiniabactin secretion 
within this space would therefore be expected to result in high local Cu(II)-Ybt concentrations. 
The distinctive ability of FyuA to maintain Fe(III)-Ybt import in the presence of excess Cu(II)-
Ybt (Fig 7) suggests that the yersiniabactin import system may have adapted to copper-rich 
intracellular compartments. Specifically, the yersiniabactin system distinguishes yersiniabactin 
bound to copper versus iron to avoid the toxic metal (copper) while still importing the 
nutritionally valuable one (iron). This is in agreement with previous works showing Ybt-
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mediated copper resistance in intracellular compartments (17, 18), as well as observations by 
Braud et al., where expression of the siderophores pyoverdine and pyochelin by Pseudomonas 
aeruginosa increased copper resistance (42). Further investigation is necessary to determine 
where these compartments might exist during urinary tract pathogenesis. 
 
Cu(II)-Ybt’s distinctive ability to be transported at low concentrations without inhibiting Fe(III)-
Ybt transport (Fig. 7) suggests a specific molecular interaction with Cu(II)-Ybt. While the nature 
of this interaction is currently unclear, DFT calculations raise the possibility that the distinctive 
“open” pentacoordinate form (Fig. 3) of Cu(II)-Ybt could enable protein interactions with the 
free carboxylic acid, the open axial Cu coordination site, or both. Copper specificity in E. coli 
ectopically expressing FyuA (Fig. 7) suggests that this protein may be the relevant discriminator. 
This could occur through an unrecognized allosteric site or through an intermediate site occupied 
during transport. Although TonB-dependent transporters (TBDT) have been the subject of 
multiple structural analyses, a better mechanistic understanding of their transport will be 
necessary to discern precisely how Cu(II)-Ybt-specificity is achieved (3, 43).  
 
Outside of endosomal compartments where copper availability and yersiniabactin concentrations 
are low, the yersiniabactin system may function as a copper scavenging (chalkophore) system 
(44) (Fig. 6, 7). Yersiniabactin’s ability to form stable, FyuA-importable complexes with 
physiologically relevant copper, nickel, cobalt, and chromium ions may supply trace nutrients for 
pathogens beyond iron. Because bacterial metalloproteomes are incompletely understood; the 
full extent of transition metal demands exhibited by pathogenic bacteria at various stages of 
infection are unclear (45). The lack of stable zinc and manganese Ybt complexes are notable. 
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Recent work by Bobrov et al. linked Ybt to a distinctive, non-TonB-dependent zinc import 
pathway in Yersinia pestis involving the Yersinia HPI gene ybtX (46). However as MG1655 
lacks ybtX, our transport results do not implicate this gene in transport of the stable metal-Ybt 
complexes observed here. As with Bobrov et al., we were unable to observe stable Zn(II)-Ybt 
and further found that Zn(II) does not interfere with Fe(III)-Ybt formation. The selectivity of Ybt 
to bind Fe(III) despite excess Zn(II) may be advantageous for UPEC infecting males where it 
may encounter excess zinc in prostate glands (47–49). Future studies of the UPEC 
metalloproteome will help fully discern roles for yersiniabactin-delivered metals in UTI 
pathogenesis. 
 
The results described here suggest an approach to define siderophore-associated metallomes. 
Prior studies have demonstrated siderophore-mediated uptake of certain non-ferric metals in 
other siderophore systems using spectrometric and radiolabeling approaches (42, 50–52).  The 
quantitative mass spectrometry approach developed here allows us to directly compare 
siderophore interactions with a wide range of non-radioactive metals. Although this method is 
insensitive to transient or unstable Ybt complexes, weak complexes would appear to be of less 
biological significance unless stabilized by an additional component such as a binding protein. 
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CHAPTER TWO: FIGURES 
  
Figure 1. Mass spectrometric neutral loss screen reveals multiple stable metal-Ybt 
complexes. Liquid chromatography-constant neutral loss (LC-CNL) chromatograms reveal new 
chromatographic peaks corresponding to different stable metal Ybt complexes in solutions 
combining apo-Ybt (top) and different metal ions. The established Ybt ligands iron, copper, and 
gallium were used as positive controls while Ybt solutions containing chromium, cobalt and 
nickel revealed new peaks that differ from apo-Ybt or other known metal-Ybt complexes. Ybt 
solutions containing zinc and manganese did not reveal new peaks. 
2 4 6 min
+ Ni(II)
+ Co(II)
+ Cr(II)
+ Cu(II)
+ Fe(III)
+ Ga(III)
apo-Ybt
+ Mn(II)
+ Zn(II)
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Figure 2. MS and MS/MS spectral analyses reveal non-ferric metal-Ybt complexes. (A) MS 
spectrum of chromium-Ybt exhibits a base peak at m/z 531 consistent with Cr(III) and its natural 
abundance 50Cr, 52Cr and 53Cr isotopes. (B) MS spectrum of cobalt-Ybt exhibits a base peak at 
m/z 531 consistent with 59Co(III). (C) MS spectrum of nickel-Ybt exhibits a base peak at m/z 538 
and a prominent M+2 peak consistent with Ni(II) and its 58Ni and 60Ni isotopes. (D, E, F) 
Tandem MS/MS spectra for each complex confirms the dominant neutral loss of 187 m/z units 
observed with previously characterized metal-Ybt species.  
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Figure 3. Density function theory (DFT) models structurally differentiate Cu(II)-Ybt 
complexes. Metal ion bonds predicted by DFT calculations of Ybt complexes with Fe(III), 
Cr(III), Ga(III), Ni(II),  Co(III), and Cu(II). Spin states are indicated (S, total spin; HS, high spin; 
LS, low spin).  In Cu(II)-Ybt, axial Cu-O bonds are relatively stretched (0.15 - 0.20 nm indicated 
by dashed lines) and interconvert with a competitive penta-coordinate form. Calculated position 
of charging proton(s) for mono-cationization (ESI in the mass spectrometer) are indicated in bold 
orange.  
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Figure 4. FyuA and YbtPQ are necessary for Fe(III)-Ybt-dependent growth in pathogenic 
(UTI89) and non-pathogenic (MG1655) E. coli. (A) Fe(III)-Ybt-dependent growth is limited in 
UTI89 mutants lacking FyuA and YbtPQ. In this condition, Fe(III)-Ybt is added to a rich media 
in which bioavailable ferric ions are chelated with EDDHA. (B) UTI89 strains are 
indistinguishable in the absence of Fe(III)-Ybt . (C) MG1655 pybtPQ_fyuA, which constitutively 
express both FyuA and YbtPQ, gains Fe(III)-Ybt-dependent growth. (D) MG1655 strains are 
indistinguishable in the absence of Fe(III)-Ybt. Fold increase in growth represents the ratio of 
CFU at end point over start point for each strain. Results are shown as mean ± s.d.; n=3; 
*P<0.05, **P<0.01, **P<0.001. 
0
1
2
3
UTI89 UTI89
ΔybtPQ
UTI89
ΔfyuA
*
**
fo
ld
 in
cr
ea
se
 in
 g
ro
w
th
chelated media with Fe(III)-Ybt
0
1
2
3
4
MG1655 MG1655 
pfyuA
MG1655 
pybtPQ
MG1655 
pybtPQ_
fyuA
NS
NS
***
fo
ld
 in
cr
ea
se
 in
 g
ro
w
th
chelated media with Fe(III)-Ybt
A
0
1
2
3
NS
NS
fo
ld
 in
cr
ea
se
 in
 g
ro
w
th
chelated media 
UTI89 UTI89
ΔybtPQ
UTI89
ΔfyuA
0
1
2
3
4
NS
NS
NS
MG1655 MG1655 
pfyuA
MG1655 
pybtPQ
fo
ld
 in
cr
ea
se
 in
 g
ro
w
th
chelated media
MG1655 
pybtPQ_
fyuA
B
DC
 56	  
Figure 5. Direct LC-MS/MS detection of cell-associated Fe(III)-Ybt in FyuA-expressing 
UTI89 and MG1655. Bacteria grown in Fe(III)-Ybt-containing media were extracted to quantify 
cell-associated Fe(III)-Ybt using LC-MS/MS with a 13C-labeled Fe(III)-Ybt internal standard. 
(A) Representative LC-MS/MS chromatograms of cell-associated Fe(III)-Ybt scaled to internal 
standard peaks. (B) Cell-associated Fe(III)-Ybt was abolished in an FyuA-deficient mutant and 
restored by genetic complementation. (C) Exogenous FyuA expression in MG1655 significantly 
increased cell-associated Fe(III)-Ybt levels while expression in a MG1655ΔtonB resulted in 
lower levels. (D) A positive Fe(III)-Ybt dose-response relationship was observed in MG1655 
pfyuA (black bars) but not MG1655ΔtonB pfyuA (white bars). Results are shown as nanomoles, 
mean ± s.d.; n=3; ***P<0.001.  
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Figure 6. FyuA and TonB-dependent uptake of Cu(II)-Ybt and other non-ferric complexes. 
Cell-associated metal-Ybt complexes were measured in E. coli MG1655 strains. (left) Ectopic 
FyuA expression significantly increased cell-associated metal-Ybt levels but this increase was 
significantly lower in a tonB-null mutant background. (right) tonB-null mutants exhibited lower 
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cell-associated Ybt complexes over a range of applied media concentrations. Black bars indicate 
MG1655 pfyuA while white bars indicate MG1655ΔtonB pfyuA. Results are shown as 
nanomoles, mean ± s.d.; n=3; *P<0.05, **P<0.01 and ***P<0.001. 
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Figure 7. Cu(II)-Ybt does not competitively inhibit Fe(III)-Ybt uptake. MG1655 strains 
ectopically expressing FyuA were grown in rich media with the indicated concentrations of 
Fe(III)-Ybt and 0.1µM non-iron Ybt complexes (left) or the indicated concentrations of non-iron 
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Ybt complexes and 0.1µM Fe(III)-Ybt (right). Fe(III)-Ybt levels are represented in black with 
non-ferric Ybt complexes in white. Results are shown as nanomoles, mean ± s.d.; n=3  
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Figure 8. Metal-Ybt transport model. Extracellular apo-Ybt interacts with Fe(III) (red) and 
select transition metals (light blue). Stable metal-Ybt complexes are transported through the 
outer membrane receptor, FyuA, in a TonB-dependent manner. The precise interactions between 
metal-Ybt and the inner membrane transporters YbtPQ, is not known.  
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CHAPTER TWO: SUPPLEMENTARY FIGURES 
 
Supplementary Figure 1. Fe(III)-Ybt and apo-Ybt levels do not decrease in presence of 
excess zinc ions. HPLC-purified Fe(III)-Ybt and apo-Ybt were separately incubated with excess 
zinc ions. Samples were eluted on C18 silica columns to remove unbound zinc ions and 13C-
labeled Fe(III)-Ybt was added just prior to elution to normalize for column retention. Fe(III)-Ybt 
and apo-Ybt levels were measured using MRM detection method. Relative levels were 
calculated using MRM peak areas normalized with 13C-labeled internal standard. (A) Fe(III)-
Ybt and (B) apo-Ybt levels did not change despite mixing with zinc ions in molar excess. 
Results are shown as mean ± s.d.; n=3. 
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Supplementary Figure 2. Structural confirmation of metal-Ybt complexes by stable isotope 
labeling. MS/MS of new 13C-labeled metal-Ybt complexes revealed a shifted dominant MS/MS 
neutral loss of 195 mass units, corresponding to loss of a fragment containing eight carbons as 
previously observed for Fe(III)-Ybt and Cu(II)-Ybt.  
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Supplementary Figure 3. Comparison of neutral Fe(III)-Ybt complexes. Figure and Table 
show comparison of ligand bond lengths to the ferric ion between as calculated to the published 
crystal structure (37) (structure A of four in unit cell) of neutral Fe(III)-Ybt. 
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Supplementary Figure 4. FyuA and YbtPQ are necessary for Fe(III)-Ybt-dependent 
growth in UPEC. (A) Fe(III)-Ybt-dependent growth is limited in UTI89 mutants lacking FyuA 
and YbtPQ. In this condition, Fe(III)-Ybt is added to a rich media in which bioavailable ferric 
ions are chelated with EDDHA. Plasmid-complemented mutants show restored growth with 
exogenous Fe(III)-Ybt. (B) UTI89 strains are indistinguishable in the absence of Fe(III)-Ybt in 
chelated media. 
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CHAPTER TWO: TABLES 
Table 1. Calculated metal-Ybt extinction coefficient values  
metal-Ybt local maximum (nm) extinction coefficient 
Fe(III)-Ybt 385 5295 
Cu(II)-Ybt 350 4578 
Cr(III)-Ybt 350 3948 
Ga(III)-Ybt 345 6448 
Co(III)-Ybt 370 4076 
Ni(II)-Ybt 355 5902 
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CHAPTER THREE 
The yersiniabactin-associated ATP binding cassette proteins YbtP and YbtQ enhance E. 
coli fitness during high titer cystitis 
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ABSTRACT 
The Yersinia High Pathogenicity Island (HPI) is common to multiple virulence strategies used by 
Escherichia coli strains associated with urinary tract infection (UTI). Among the genes in this 
island are ybtP and ybtQ, encoding distinctive ATP binding cassette (ABC) proteins associated 
with ferric yersiniabactin import in Yersinia pestis. In this study, we compared the impact of 
ybtPQ on a model E. coli cystitis strain during in vitro culture and experimental murine 
infections. A ybtPQ-null mutant exhibited no growth defect in standard culture conditions 
consistent with non-essentiality in this background. A growth defect phenotype was observed, 
and genetically complemented in vitro during ferric yersiniabactin-dependent growth. Following 
bladder inoculation in C3H/HEN and C3H/HeOuJ mice, this strain exhibited a profound, 
million-fold competitive infection defect in the subgroup of mice that progress to high titer 
bladder infections. These results identify a virulence role for YbtPQ during the highly 
inflammatory microenvironment characteristic of high titer cystitis. The profound competitive 
defect may relate to the apparent selection of Yersinia HPI-positive E. coli in uncomplicated 
clinical UTIs. 
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INTRODUCTION 
Urinary tract infection (UTI) is one of most common bacterial infections, affecting nearly 9 
million individuals every year (1). Uropathogenic Escherichia coli (UPEC) are responsible for 
over 80% of all community-acquired UTI cases and in some patients progresses from a localized 
bladder infection to infect the kidneys and bloodstream (2, 3). Over 50% of women acquire a 
UTI over their lifetime, with 30% suffering from recurrent UTI (4, 5). Uncomplicated UTIs 
appear to follow an ascending route of infection in which the bladder is exposed to a 
polymicrobial inoculum of intestinal bacteria that colonize the vaginal vestibule and urethra (6–
10). This early colonization event may precede patients’ visits to physicians by several days. Our 
understanding of the molecular mechanisms UPEC use to emerge from this early inoculum and 
dominate the urinary microbiome at the time of clinical UTI diagnosis remains incomplete.  
 
When an uncomplicated UTI patient’s rectal and urinary E. coli strains are compared, the urinary 
strain is more likely to carry the 30 kilobase Yersinia High Pathogenicity Island (HPI) (11). The 
Yersinia HPI is nearly ubiquitous among model uropathogenic E. coli strains, is associated with 
fluoroquinolone resistance when present in combination with the aerobactin siderophore system, 
and is typically present in over 70% of clinical urinary isolates (3, 11, 12). The Yersinia HPI 
encodes the yersiniabactin siderophore system including yersiniabactin biosynthetic enzymes in 
addition to outer and inner membrane transporters associated with metal-yersiniabactin complex 
import (13–16). Yersiniabactin is one of three genetically non-conserved E. coli siderophore 
types (yersiniabactin, salmochelin and aerobactin) that may be expressed in addition to 
enterobactin, the conserved E. coli siderophore (3, 11, 12). The Yersinia HPI is central to 
multiple E. coli urovirulence strategies, raising the possibility that it is functionally distinct from 
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other siderophore systems (12). In uropathogenic E. coli, the yersiniabactin system has been 
appreciated to facilitate importer-independent copper and reactive oxygen species resistance (17, 
18). Furthermore in Y. pestis, the yersiniabactin system is linked to zinc import (19). E. coli 
virulence may be enhanced in strains that use multiple siderophore types, including 
yersiniabactin, to overcome metal ion limitation characteristic of “nutritional immunity” (20, 21). 
These observations raise the question of whether importer-dependent functions associated with 
the Yersinia HPI such as metal ion acquisition are pathophysiologically important during UTI 
(14, 16). 
 
Seminal studies in Yersinia pestis identified several proteins that are specifically necessary for 
ferric yersiniabactin-dependent growth (14, 15). Within the Yersinia HPI, the inner membrane 
transporter genes (ybtP and ybtQ) are present in an operon that is separate from the outer 
membrane transporter gene (denoted as psn in Y. pestis, and fyuA in other bacteria) operon. Both 
operons are regulated in part by the AraC-like transcription factor YbtA (Fig 1) (13, 14, 22, 23). 
Typical of most outer membrane siderophore transporters, FyuA uses the TonB complex to 
import its cognate iron(III)-siderophore complex (Fe(III)-yersiniabactin) into the periplasmic 
space (15, 16, 24). Unlike most siderophore-associated inner membrane transporters, ybtP and 
ybtQ are overlapping genes (by 40 nucleotides) that each encode half of an inner membrane 
ATP-binding cassette (ABC) transporter, each with unusual amino-terminal membrane-spanning 
domains and carboxy-terminal ATPases (14). It is unclear whether these unusual structural 
features correspond to atypical or complex functionality. While siderophore-associated ABC 
transporters are typically implicated in ferric siderophore transport, some members of this family 
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possess additional signaling roles (25). Metabolomic comparisons also raise the possibility that 
YbtP and Q may exert functions distinct from ferric yersiniabactin utilization in UPEC (26). 
 
Overall expression of the yersiniabactin system can be inferred by evidence of yersiniabactin 
biosynthesis as well as serological and transcriptional evidence of ybtP, ybtQ and fyuA 
expression during mouse and human cystitis (17, 27–29). Beyond UTI, ybtPQ mutants in 
Yersinia pestis and Klebsiella pneumoniae exhibit diminished virulence in mouse models of 
bubonic plague and pneumonia, respectively (14, 30). ybtP and ybtQ homologues in 
Pseudomonas aeruginosa and Mycobacterium tuberculosis also affected virulence in a burned 
mouse model of sepsis and mouse aerosol infection model (31, 32). The broad spectrum of 
pathogens associated with these distinctive bacterial proteins makes their associated functions an 
intriguing target for future virulence-associated therapies. 
 
In this study, we sought to determine whether YbtP and YbtQ affect urinary tract infection 
pathogenesis. Using a combined bacteriologic and liquid chromatography-mass spectrometry 
approach, we found that YbtPQ is necessary for ferric-Ybt dependent growth but not Ybt 
synthesis in a UPEC strain. We next compared isogenic wild type and ybtPQ mutant strains in an 
experimental murine cystitis model using C3H/HeN and C3H/HeOuJ mice, which are known to 
develop distinctive high titer, persistent infections with UPEC. Uropathogenic E. coli lacking 
ybtPQ exhibited a profound competitive fitness defect during high titer infections but not during 
low iron liquid culture conditions. These results are consistent with an important role for YbtP 
and Q in inflamed bladder microenvironments during UTI infection pathogenesis.   
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EXPERIMENTAL PROCEDURES 
Bacterial strains, plasmids and culture conditions 
Uropathogenic E. coli isolate UTI89, which encodes the enterobactin, salmochelin and 
yersiniabactin siderophore systems, was used in this study (33, 34). Strains were grown in LB 
agar (Becton, Dickson and Company) or M63 minimal medium supplemented with 0.2% 
glycerol (v/v) and 10 mg ml-1 niacin (Sigma) with antibiotics as appropriate (11). Ampicillin 
(100 µg ml-1, Goldbio) and kanamycin (50 µg ml-1, Goldbio) were used for strain selection. 
UTI89 mutant strains used in this study are listed in Table 1. In-frame deletions in UTI89 were 
made using the lambda Red recombinase method with pKD4 or pKD13 as templates (35). PCR 
with flanking primers were used to confirm deletions. Antibiotic resistance insertions were 
removed by transforming strains with pCP20 expressing FLP recombinase. YbtPQ-expressing 
plasmid was constructed with the pTrc99a vector (36) and using standard PCR and 
recombination techniques.  
 
Yersiniabactin and 13C-yersiniabactin preparation 
Apo-Ybt was generated from UTI89ΔentB grown in M63 minimal medium supplemented with 
0.2% glycerol (v/v) and 10 mg ml-1 niacin (Sigma) as previously described (17). 13C-Ybt was 
generated by growing UTI89Δfur in medium supplemented 13C-labeled glycerol as previously 
described (17). Ferric-Ybt complexes were produced by adding iron(III) chloride (Sigma) to 
apo-Ybt. Ferric-Ybt was applied to a methanol conditioned C18 silica column (Sigma) and 
eluted with 80% methanol as previously described (16). Eluates were lyophilized overnight. 
Dried samples were resuspended in deionized water and purified through high-performance 
liquid chromatography using C18 silica column (Whatman Partisil). Ferric-Ybt containing 
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fractions were collected, dried down using a lyophilizer and resuspended in deionized water. 
Stock ferric-Ybt quantification was carried out using previously described extinction coefficient 
(16). Sample ferric-Ybt levels were quantified in multiple reaction monitoring mode using 
known collision-induced dissociation fragmentations and 13C-labeled Fe(III)-Ybt internal 
standards.  
 
Fe(III)-Ybt dependent growth 
After overnight growth in M63 minimal medium, strains were normalized for starting OD600 in 
M63 with 2 mM EDDHA (Complete Green Company). 1 µM HPLC-purified Fe(III)-Ybt was 
added to strains and grown for 18 hours in 37 °C with shaking, as previously described (16). 
Bacterial growth was measured using OD600 readings.  
 
Mouse infections 
Bacteria for infection were prepared as previously described (37). Six to seven week old female 
C3H/HeN (Harlan) and C3H/HeOuJ (JAX) were transurethrally infected with a 50 µL 
suspension containing 1 x 107 CFU of UTI89 or UTI89ΔybtPQ in PBS while anesthetized under 
4% isofluorane (37, 38). For competitive infections, mice were infected with a 50 µL combined 
suspension containing 5 x 106 CFU each of UTI89 and UTI89ΔybtPQ::KanR in PBS while 
anesthetized under 4% isofluorane. At indicated time points, mice were sacrificed by cervical 
dislocation under isofluorane anesthesia and bladders and kidneys aseptically removed. Organs 
were homogenized in PBS and were then serially diluted and 50 µL total of each dilution was 
spotted onto LB agar plates and LB agar plates with 50 µg/mL kanamycin where appropriate. 
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Competitive indices (CI) were calculated by using UTI89 as the reference strain, as follows: CI = 
(UTI89CFU out / UTI89CFU in) / (UTI89ΔybtPQ::KanR CFU out / UTI89ΔybtPQ::KanR CFU in) (39). 
 
Bladder intracellular bacterial communities 
Bladders were aseptically removed at 6 hours post infection to count the number of IBCs. 
Harvested bladders were bisected, splayed on silicone plates, and fixed in 2% paraformaldehyde. 
IBCs were quantified by LacZ staining of whole bladders as previously described (40).  
 
In vitro co-growth experiments 
Bacteria for co-growth experiments were prepared the same as mice infections described above. 
5 µL combined suspension containing 5 x 106 CFU each of UTI89 and UTI89ΔybtPQ::KanR in 
PBS were inoculated to 5 mL M63 minimal medium and grown in 37 °C statically or shaking as 
indicated. At indicated time points, cultures were removed and serially diluted with 50 µL total 
of each dilution spotted onto LB agar plates and LB agar plates with 50 µg/mL kanamycin where 
appropriate. 
 
Statistical analysis 
Student’s t-test was used to compare yersiniabactin biosynthesis levels between paired strains. 
Two-tailed Mann-Whitney U test was used to compare bladder and kidney colonization levels 
and IBC counts between UTI89 and UTI89ΔybtPQ. Wilcoxon signed rank test was used to 
compare the log of competitive indices to a theoretical median of 0. Statistics and graphs were 
generated using GraphPad Prism 5 (GraphPad software). 
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RESULTS 
ybtPQ deletion does not affect growth in ferric-Ybt independent conditions 
To investigate the role of YbtPQ in uropathogenic E. coli growth, we first measured growth of 
the model UPEC strain UTI89 in nutrient-rich LB medium as well as M63 minimal medium. 
UTI89ΔybtPQ growth was indistinguishable from wild type UTI89 in both media conditions 
(Fig 2A, B). Addition of the ferric ion chelator EDDHA (2mM), which sequesters Fe(III) and 
renders it poorly accessible to siderophores, to M63 minimal medium prior to inoculation 
diminished growth of both strains to a similar degree. Addition of 1 µM purified Fe(III)-Ybt 
reversed EDDHA-mediated inhibition of wild type UTI89 but not UTI89ΔybtPQ. Genetic 
complementation with plasmid-encoded ybtPQ restored UTI89ΔybtPQ growth to wild type 
levels in this EDDHA/Fe(III)-Ybt condition (Fig 2C, D). Insertion of empty vector did not 
restore UTI89ΔybtPQ growth to wild type levels in this EDDHA/Fe(III)-Ybt condition (Data not 
shown). These results are consistent with YbtPQ as non-essential genes that permit Fe(III)-Ybt to 
be used as an iron source in UPEC. 
 
ybtPQ is not required for yersiniabactin synthesis in UPEC 
ybtPQ shares an operon with the yersiniabactin biosynthetic gene ybtS (Fig 1). To determine 
whether ybtPQ deletion exerts pleotropic effects upon Ybt synthesis in UPEC, we compared Ybt 
secretion between wild type UTI89, UTI89ΔybtPQ::KanR (Fig 3A) and UTI89ΔybtPQ (Fig 3B) 
in M63 minimal medium. Yersiniabactin production by UTI89ΔybtS was undetectable while 
UTI89ΔybtPQ::KanR was comparable to that of wild type UTI89. Plasmid-complemented 
UTI89ΔybtPQ::KanR showed a small but significant increase in Ybt synthesis compared to 
UTI89. UTI89ΔybtPQ also showed no difference in Ybt biosynthesis compared to wild type 
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UTI89. These results show that yersiniabactin biosynthesis is preserved in UTI89 ybtPQ deletion 
mutants, similar to previous results seen in Y. pestis and Y. enterocolitica (14, 23). These results 
also support a function for ybtPQ in UPEC that is distinct from yersiniabactin biosynthesis.  
 
Individual infections by wild type and ybtPQ mutants in C3H/HeN mice 
We hypothesized that loss of ybtPQ would affect in vivo fitness during urinary tract infection. 
We tested this in C3H/HeN mice (homozygous for the retinal degeneration allele Pde6brd1), 
where a 107 CFU E. coli transurethral inoculum causes an infection involving epithelial cell 
invasion followed by a bifurcation to high and low CFU values that are evident as soon as 3 days 
post infection (38). The high CFU mice exhibit high titer (>104 CFU per organ) bladder 
colonization by 4 weeks post infection that is characterized by urothelial hyperplasia and high 
levels of inflammation (37, 38, 41). We first conducted single strain inoculations with UTI89 or 
UTI89ΔybtPQ. Bladder and kidneys were harvested at 7 and 14 days post infection, and CFU 
were determined for both strains (Fig 4). As previously observed, mice infected with wild type 
UTI89 exhibited a bimodal distribution of bladder CFU at 7 and 14 days post-infection (dpi) 
with one group greater than 105 CFU/bladder and the other less than 104 CFU/bladder. Mice 
infected with UTI89ΔybtPQ showed no statistically significant differences in CFU for both 
bladder and kidneys compared to wild type UTI89 (Fig 4A, B). These results indicate that 
YbtPQ is not required for the development of acute and persistent high titer colonization in 
single strain infections.  
 
Bladder intracellular bacterial community assessment 
 84	  
To further assess the role of YbtPQ in acute cystitis, we quantified the formation of bladder 
intracellular bacterial communities (IBC). IBCs are biofilm-like aggregation of UPEC that have 
invaded and subsequently replicated in the cytoplasm of bladder superficial umbrella cells (42, 
43). IBCs have been observed during acute bladder infection, up to 24 hours post-inoculation 
(27, 43). C3H/HeN mice were infected with 107 CFU of UTI89ΔybtPQ or wild type UTI89. 
Bladders were harvested at 6 hours post infection with IBC quantification by LacZ staining (Fig 
5). IBCs were observed during UTI89ΔybtPQ infections and the number of IBCs per bladder 
were not significantly different from those observed during wild type UTI89 infections. These 
results indicate that YbtPQ is not required for IBC development.  
 
Competitive infections and in vitro co-growth with wild type and ybtPQ mutant 
Previous observations suggest that uncomplicated UTI originate with polymicrobial inoculation 
of the urinary tract and that patient rectal E. coli strains with the Yersinia High Pathogenicity 
Island are preferentially recovered from patient urine once the infections become symptomatic 
(10, 11). To determine if loss of ybtPQ function would affect fitness during mixed inoculation 
with a wild type strain with intact ybtPQ, we measured wild type UTI89 and 
UTI89ΔybtPQ::KanR in competitive infections. We infected C3H/HeN mice with a 107 total 
CFU inoculum consisting of a 1:1 ratio of wild type and mutant UTI89. In both bladder and 
kidneys, we saw a significant (p<0.05) increase in mean competitive index (CI) values over time, 
demonstrating that wild type UTI89 outcompetes the mutant strain (Fig 6A, B). By 3-days post 
infection, a markedly bimodal CI distribution became apparent in bladders, with one group 
demonstrating CI greater than 104 (10,000-fold increase in wild type selection) and the other 
with CI less than 101 (10-fold increase in wild type selection). This separation was widened by 7 
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and 14-days post infection. Similar progression toward a bimodal CI distribution was observed in 
kidneys. Neither a high CI nor a bimodal distribution was observed in competitive inoculation of 
wild type UTI89 and UTI89ΔybtPQ::KanR into M63 minimal medium under shaking or static 
conditions at 37 °C (Fig 6C, D). UTI89ΔybtPQ::KanR showed only a small competitive defect 
against the wild type strain in both static and shaking conditions near 7-days post inoculation. 
Together, these results suggest that UPEC lacking YbtPQ are at a marked competitive 
disadvantage in the distinctive host environment of the mouse cystitis model.  
 
The unusual bimodal CI distribution observed here resembles the bimodal distribution of bladder 
CFU values in this C3H/HeN mouse cystitis model (38) (Fig 4). To determine whether the CI 
distribution is related to infection severity, we compared CI values with total CFU (Fig 7A, B). 
In the bladder, the high CI group corresponded to high titer mice while the low CI group 
corresponded to low titer mice. CI values within the high titer group progressively increased over 
the course of 3, 7 and 14-day infections until nearing the maximum resolvable CI limit (based on 
CFU). A similar relationship was observed in kidneys, although CFUs were more evenly 
distributed and CI values appeared to approach the maximum resolvable limit for all CFU 
values. Together, these results suggest that the persistent high titer, but not low titer, bladder 
infection environment strongly favors UPEC with an intact yersiniabactin import system. This 
may relate to the apparent selection of E. coli strains with the Yersinia HPI in UTI patients (11). 
 
Competitive infections by wild type and ybtPQ mutants in C3H/HeOuJ mice  
To determine whether loss of YbtPQ has similar effects during infection in other mouse 
backgrounds, we competitively inoculated C3H/HeOuJ mice (homozygous for the retinal 
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degeneration allele Pde6brd1) with wild type UTI89 and UTI89ΔybtPQ::KanR as described 
previously for C3H/HeN mice. C3H/HeOuJ mice have been shown previously to be highly 
susceptible to persistent bladder and kidney infections from UPEC (38, 44). Similar to results 
seen in C3H/HeN mice, we saw significant increase (p<0.05) in mean competitive index (CI) 
values over time in both bladder (Fig 8A) and kidneys (Fig 8C). When we compared CI values 
with total CFU, we again observed high CI group corresponding to high titer mice and the low 
CI group corresponding to low titer mice in both bladder (Fig 8B) and kidneys (Fig 8D), similar 
to C3H/HeN mice.  
 
We also conducted single strain inoculations with UTI89 or UTI89ΔybtPQ. Similar to results 
seen in C3H/HeN mice, mice infected with wild type UTI89 exhibited a bimodal distribution of 
bladder CFU. In mice infected with UTI89ΔybtPQ, there was a significant decrease by 14 days 
in mean CFU/bladder when compared to wild type UTI89 (Fig 9A). Despite observing 
significantly lower CFU in the kidneys at 3-days post infection with UTI89ΔybtPQ, there were 
no statistically significant differences in CFU/kidney at later time points (Fig 9B). These results 
suggest that UPEC with an intact yersiniabactin import system have greater fitness during 
persistent high titer bladder infections. 
 87	  
DISCUSSION 
In this study, we show that the UPEC-encoded ATP-binding cassette transporters YbtP and Q 
promote bacterial fitness during urinary tract infections. YbtPQ most profoundly affected fitness 
in the highly inflammatory infection environment of high titer mouse cystitis. While wild type 
UPEC exhibited up to one million-fold greater survival than co-inoculated ybtPQ deletion 
mutants in murine infections, no such competitive defect was noted during in vitro cultures. This 
is the first report of a role for YbtPQ during E. coli urinary tract infection and is among the 
highest competitive defects reported for a non-conserved, non-essential gene during 
experimental cystitis. It is notable that this phenotype is evident in UTI89, where in vitro iron 
uptake by yersiniabactin is redundant with the enterobactin and salmochelin siderophore 
systems. Together, these data suggest that YbtPQ contributes distinctive functions that facilitate 
the urovirulence of E. coli carrying the Yersinia High Pathogenicity Island.  
 
Previous work has found that in patients with intestinal colonization by multiple E. coli strains, 
strains possessing the Yersinia HPI are preferentially isolated from patient urine at the time of 
UTI diagnosis (11). Here, the profound competitive disadvantage for YbtPQ-null UPEC during 
high titer infections – but not in vitro culture – suggests a similar advantage for Yersinia HPI-
expressing E. coli in the polymicrobial inoculum preceding uncomplicated UTIs in humans. 
Features of the high titer infection state in C3H/HeN and C3H/HeOuJ suggest aspects of the host 
response that may select against YbtPQ-null UPEC. In these infections, up to 20% of bladder 
UPEC are intracellular within urothelial cells, macrophages and neutrophils. The high titer 
infection state is also characterized by a robust inflammatory response, which was shown to be 
required for the development of chronic cystitis (38, 45). If so, a virulence defect during single 
 88	  
strain infections may be more difficult to resolve if the mutant strain elicits a less vigorous 
inflammatory response than what is present during a mixed infection with wild type UPEC. As 
such, a potentially greater inflammatory response during a mixed infection may favor wild type 
UPEC survival. These inflammatory responses may resemble those present during the 2-3 days 
of “pre-clinical UTI” that pre-date patients’ decisions to seek treatment for UTI symptoms (5). 
The current study thus raises the possibility that the yersiniabactin import pathway equips UPEC 
to better overcome barriers to growth imposed by inflammatory microenvironments in the 
infected host. 
 
With the notable exception of Y. pestis YbtP and Salmonella enterica serovar Typhimurium IroC 
(14, 46), experimental infection studies have tended to focus upon the TonB-dependent outer 
membrane siderophore transporters, rather than siderophore-associated inner membrane ABC 
protein components. A recent study using a fyuA-deficient UPEC strain found a lower 
competitive defect in the bladder than was observed for ybtPQ-deficient UPEC in the present 
study. In contrast, the single strain infection defect was somewhat more pronounced for fyuA 
than ybtPQ mutants (29, 47–50). A previous study using a tonB-deficient UPEC strain yielded 
similar results to the fyuA mutant (51). The notable differences between fyuA and ybtPQ mutants 
are interesting and may derive from different strain backgrounds or distinctive features of the 
C3H background mice used in this study. It is possible that robust inflammation in C3H mice 
increases UPEC outer membrane permeability (through antimicrobial peptides), making outer 
membrane transporters relatively less critical for metal-yersiniabactin import (52–54). Lastly, the 
marked competitive advantage observed with YbtPQ may derive from additional virulence 
functions that are not directly related to yersiniabactin import. For example, Lv et al. have shown 
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that a UTI89 ybtP mutant exhibits a significant change in cellular cysteine compared an isogenic 
fyuA mutant (26). More direct experimental functional comparisons between outer or inner 
membrane siderophore import proteins will be necessary to understand how functionally distinct 
these proteins may be.  
 
Structurally diverse ABC cassette transporters such as YbtPQ have been the subject of extensive 
pharmacologic study in both eukaryotes and prokaryotes, making this an appealing class of 
targets for next generation anti-infectives (55, 56). Structural differences in ABC transporters 
between humans and bacteria may enable antibiotics with specificity to be identified. Numerous 
functions have been described for the bacterial ATP-binding cassette transporter superfamily in 
both Gram positive and Gram negative pathogens (25, 55–57). Further investigation on the 
mechanisms of ABC transporters will provide insight to their role during pathogenesis as well as 
allow development of countermeasures targeting these transporters.   
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CHAPTER THREE: FIGURES 
 
Figure 1. Genetic organization of UTI89 Yersinia High Pathogenicity Island (HPI). The non-
conserved ~30 kb UTI89 Yersinia HPI encodes 11 genes in 4 operons. Promoters are designated 
by white arrows. Direction of arrow represents direction of transcription/translation for 
respective operon.  
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Figure 2. YbtPQ is required for Fe(III)-Ybt-dependent growth in UPEC. Growth of UTI89 
(black circle), UTI89ΔybtPQ (red square), and UTI89ΔybtPQ pybtPQ (blue triangle) were 
indistinguishable in nutrient-rich Lysogeny broth (LB) medium (A) and nutrient-limiting M63 
minimal medium supplemented with 0.2% glycerol (v/v) and 10 mg ml-1 niacin (B). In M63 
minimal medium chelated with 2 mM EDDHA, all strains show decreased growth (C). This 
growth defect was rescued for UTI89 and UTI89ΔybtPQ pybtPQ upon addition of exogenous 1 
µM Fe(III)-Ybt to the chelated media (D). Results are shown as mean ± s.d.; n=3.  
LB
0 5 10 15 20
0.0
0.5
1.0
1.5
2.0
2.5
hours
O
D
60
0
M63 / glycerol
0 5 10 15 20
0.0
0.5
1.0
1.5
2.0
2.5
hours
UTI89
UTI89ΔybtPQ
UTI89ΔybtPQ pybtPQO
D
60
0
M63 / glycerol / EDDHA
0 5 10 15 20
0.0
0.2
0.4
0.6
0.8
1.0
hours
O
D
60
0
M63 / glycerol / EDDHA / 1µM Fe(III)-Ybt
0 5 10 15 20
0.0
0.2
0.4
0.6
0.8
1.0
hours
UTI89
UTI89ΔybtPQ
UTI89ΔybtPQ pybtPQ 
O
D
60
0
A B
C D
 93	  
 
Figure 3. YbtPQ is not required for Ybt synthesis in UPEC. Yersiniabactin production was 
determined from culture supernatants of UTI89 strains using quantitative LC-MS/MS methods. 
While salicylate synthesis-deficient UTI89ΔybtS showed decreased Ybt production, 
UTI89ΔybtPQ::KanR (A) and UTI89ΔybtPQ (B) showed no difference compared to wild type. 
Plasmid-complemented UTI89ΔybtPQ::KanR pybtPQ (A) and UTI89ΔybtPQ pybtPQ (B) 
showed increased Ybt synthesis compared to wild type. Results are shown as mean ± s.d.; n=3. 
*p < 0.05 **p < 0.005, ***p < 0.0005. 
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Figure 4. In vivo single strain infections in C3H/HeN mice background. Bacterial titers at the 
7 days (green) and 14 days (red) following inoculation with 107 CFU UTI89 () or 
UTI89ΔybtPQ (p) in (A) bladder and (B) kidneys from C3H/HeN mice are shown. Statistical 
significance was assessed using the two-tailed Mann-Whitney U test. Bars indicate mean values.  
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Figure 5. Bladder intracellular bacterial communities at 6 hours post infection in C3H/HeN 
mice. Intracellular bacterial communities (IBC) were quantified by LacZ staining at 6 hours post 
infection from 107 CFU UTI89 or UTI89ΔybtPQ in C3H/HeN mice. Statistical significance was 
assessed using the two-tailed Mann-Whitney U test. Bars indicate mean values.  
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Figure 6. In vivo competitive infection in C3H/HeN mice and in vitro co-culture growth. 
UTI89 showed significant competitive advantage against UTI89ΔybtPQ::KanR during in vivo 
competitive infections compared to in vitro co-culture growth. UTI89 and UTI89ΔybtPQ::KanR 
were mixed 1:1 to 107 total CFU prior to co-infection and co-culture. Competitive infections 
were performed in C3H/HeN mice and bacterial titers in (A) bladders and (B) kidneys were 
determined. UTI89 strains were co-cultured in M63 minimal medium under shaking (C) and 
static (D) conditions. Each symbol represents a datum from an individual mouse or culture. 
Statistical significance was assessed using the Wilcoxon signed rank test with log10 of CI of 0 as 
the theoretical median (dotted line). Numbers indicate median values with * denoting those with 
p < 0.05. Bars indicate mean values.    
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Figure 7. In vivo competitive infections in C3H/HeN mice show correlation with bacterial 
levels. Presenting competitive index values against total bacterial titers from (A) bladder and (B) 
kidneys of C3H/HeN mice revealed mice with large competitive indices had high bacterial titer 
while mice with low competitive indices presented low bacterial burden in each organ.   
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Figure 8. In vivo competitive infection with C3H/HeOuJ mice. UTI89 showed significant 
competitive advantage against UTI89ΔybtPQ::KanR during in vivo competitive infections with 
C3H/HeOuJ mice. UTI89 and UTI89ΔybtPQ::KanR were mixed 1:1 to 107 total CFU prior to co-
infection. Competitive indices were calculated from bacterial titers collected from (A) bladder 
and (C) kidneys. Competitive index values are presented against total bacterial titers from (B) 
bladder and (D) kidneys. Each symbol represents a datum from an individual mouse. Statistical 
significance was assessed using the Wilcoxon signed rank test with log10 of CI of 0 as the 
theoretical mean (dotted line). *p < 0.05. Bars indicate mean values. 
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Figure 9. In vivo single strain infections in C3H/HeOuJ mice backgrounds. Bacterial titers at 
day 3 (blue), day 7 (green) and day 14 (red) following inoculation with 107 CFU UTI89 () or 
UTI89ΔybtPQ (p) in (A) bladder and (B) kidneys from C3H/HeOuJ mice. Statistical 
significance was assessed using the two-tailed Mann-Whitney U test with *p < 0.05, **p < 0.01. 
Bars indicate mean values. 
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CHAPTER THREE: TABLES 
Table 1. UTI89 mutants strains used in this study 
strain relevant properties reference 
UTI89ΔybtS salicylate synthase deletion, yersiniabactin biosynthesis 
mutant  
(11) 
UTI89ΔybtPQ ATP-binding cassette transporter deletion, yersiniabactin 
transport mutant 
(26) 
UTI89ΔybtPQ::KanR Kanamycin resistant insert in place of ATP-binding 
cassette transporter, yersiniabactin transport mutant 
(26), this 
study 
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CHAPTER FOUR 
Metal acquisition by the virulence-associated yersiniabactin metallophore system 
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ABSTRACT 
Uropathogenic Escherichia coli express several distinct siderophore systems during human 
infections. Of these, the virulence-associated siderophore yersiniabactin binds divalent copper 
ions during infections, with copper(II) yersiniabactin a transport substrate of the yersiniabactin 
outer membrane importer FyuA. Here, we use a mass spectrometric approach to investigate the 
interactions of yersiniabactin with its ATP-binding cassette inner membrane transporters YbtP 
and YbtQ, and the intracellular fate of metal yersiniabactin complexes. In fyuA and ybtPQ-
expressing E. coli, iron, copper and nickel are released from their respecitve intracellular metal 
yersiniabactin complexes, with apo-yersiniabactin recycled to the extracellular medium. 
Intracellular gallium(III) yersiniabactin, however, remained stable with no detectable apo-
yersiniabactin recycling, while physiologic reducing agents facilitated the release of iron from 
yersiniabactin. These results are consistent with yersiniabactin as part of a metallophore system 
able to deliver select transition metals to uropathogenic E. coli.  
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INTRODUCTION 
Many bacterial pathogens synthesize and secrete chemically diverse specialized metabolites 
called siderophores to scavenge for ferric iron (Fe(III)) (1). Uropathogenic E. coli (UPEC) 
isolates can express multiple siderophore systems consisting of enterobactin (which is 
genetically conserved in all E. coli) in combination with salmochelin, aerobactin and/or 
yersiniabactin, even though only a single siderophore system is required for iron-dependent 
growth in iron-chelated culture conditions (2). Of these, the yersiniabactin (Ybt) system is the 
most frequently-carried, non-conserved siderophore system in UPEC (2, 3). The multi-operon 
Yersinia High Pathogenicity Island (HPI) consists of genes encoding Ybt biosynthesis proteins, a 
transcription factor (ybtA), an outer membrane import protein (fyuA), and putative inner 
membrane transporters (ybtP, Q) (4–6). Yersinia HPI genes are highly upregulated during 
experimental mouse cystitis with Ybt inner membrane proteins enhancing UPEC fitness during 
competitive high titer mouse cystitis (7, 8). Furthermore Ybt has been directly detected in the 
urine of UTI patients infected with Ybt-expressing pathogens (9). These findings combined are 
consistent with a pathogenic gain-of-function role attributed to the yersiniabactin system.  
 
Recent works have shown both copper and iron complexes with Ybt during human and 
experimental mouse cystitis, suggesting a potential gain-of-function by the Ybt system through 
interactions with non-iron metal ions (9, 10). Copper homeostasis is critical for microbes as 
copper is used as a potent antimicrobial agent by the host at elevated concentrations, but it is also 
an essential micronutrient acting as a cofactor for several microbial enzymes including NADH 
dehydrogenase, cytochrome oxidase, and copper/zinc superoxide dismutase (11–14). Therefore 
in an intracellular compartment where UPEC are exposed to high copper concentrations, Ybt 
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may protect UPEC by sequestering host copper ions and catalyzing superoxide dismutation (9, 
10, 15). However in copper-deficient environments, Ybt may be used to import copper ions to 
UPEC. The Ybt outer membrane importer (FyuA) was recently found to be a promiscuous 
transporter of metal-Ybt complexes, including Cu(II)-Ybt (16), but it has been unclear whether 
non-iron metal-Ybt complexes share similar intracellular fates as Fe(III)-Ybt. Methanobactin, a 
siderophore-like molecule secreted by methanotrophic Gram-negative bacteria, is notable in its 
delivery of copper but it is unclear whether pathogenic bacteria share this strategy (17, 18). If 
Ybt delivers physiologic metal ions in addition to iron, Ybt may function as a metallophore 
system beyond its classic iron scavenging pathway to overcome the effects of nutritional 
immunity by the host (19). 
 
For numerous Gram-negative bacteria, ferric-siderophore complexes must first be actively 
transported to the periplasm through dedicated outer membrane transporters powered by the 
TonB complex (16, 20–22). These ferric-siderophore complexes or the iron released from them, 
are then subsequently transported to the cytoplasm through inner membrane ATP-binding 
cassette transporters (6, 23–25). In Gram-negative bacteria, two mechanisms of iron release from 
ferric-siderophore complexes have been described previously. One mechanism involves 
siderophore complex hydrolysis, seen with ferric-enterobactin in E. coli where an esterase 
hydrolyzes the cyclic triester (26–28). Another pathway involves reduction of the coordinated 
Fe(III) to Fe(II), in which Fe(II) has significantly lower binding affinity for the siderophore. 
Following iron release through reduction, the siderophore is recycled into the extracellular 
matrix. This mechanism has been shown in siderophore systems in E. coli including ferrichrome 
and ferrioxamine B, as well as for other virulence-associated siderophores pyoverdine and 
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mycobactin in Pseudomonas aeruginosa and Mycobacterium tuberculosis respectively (25, 29–
32). To date, the molecular sequence of events by which iron or other physiologic metals are 
released from Ybt complexes is incompletely understood, as enzymes associated with this role 
have yet to be identified on the Yersinia HPI (6, 21). Siderophore biosynthesis requires energy 
and cellular building blocks, both of which may be scarce during an infection (33, 34). 
Siderophore recycling may therefore decrease the cellular metabolic burden by providing an 
alternative option to siderophore de novo synthesis.  
 
In this study, we sought to investigate the intracellular fate of metal-Ybt complexes. Using a 
combined bacterial genetics and quantitative mass spectrometric approach, we showed that in 
fyuA and ybtPQ-expressing E. coli, intracellular Fe(III)-Ybt is dissociated with apo-Ybt 
subsequently recycled, while intracellular Ga(III)-Ybt remains intact. Consistent with these 
findings, physiologic reducing agents facilitated iron release from Ybt. Furthermore in fyuA and 
ybtPQ-expressing E. coli, intracellular Cu(II)- and Ni(II)-Ybt complexes are dissociated with 
apo-Ybt subsequently recycled. A radiolabeling approach showed copper remains intracellular 
upon delivery through Cu(II)-Ybt. Together these results are consistent with Ybt as a 
metallophore that delivers physiologic metal ions to UPEC.  
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EXPERIMENTAL PROCEDURES 
Bacterial strains, plasmids and culture conditions 
Uropathogenic E. coli isolates UTI89 and CFT073, and the non-uropathogenic K-12 E. coli 
isolate MG1655 were used in this study (1–3). Strains were grown in LB agar (Becton, Dickson 
and Company), LB broth (Becton, Dickson and Company or M63 minimal salts media (4) with 
antibiotics as appropriate. Ampicillin (100µg ml-1, Goldbio), chloramphenicol (25µg ml-1, 
Goldbio) were used for plasmid selection. Arabinose (0.2% v/v) was used for plasmid induction. 
In-frame deletions in UTI89 were made using the standard red recombinase method, using pKD4 
or pKD13 as a template (5). Antibiotic resistance insertions were removed by transforming the 
strains with pCP20 expressing the FLP recombinase. Plasmids were made using the pTrc99a 
vector (6) or a modified pBAD33 vector (7), with genes cloned in using standard PCR and 
recombination techniques.  
 
Yersiniabactin preparation 
Apo-Ybt was generated from UTI89ΔentB grown in M63 minimal salts medium supplemented 
with 0.2% glycerol (v/v) and 10mg ml-1 niacin (Sigma) as previously described (8). 13C-
salicylate labeled apo-Ybt was produced from UTI89ΔentB ΔybtS grown in M63 minimal salts 
medium supplemented with 0.2% glycerol (v/v), 13C-labeled salicylic acid and 10mg ml-1 niacin 
(Sigma). 13C-Ybt was produced by growing UTI89Δfur strain in media supplemented with 13C-
labeled glycerol as previously described (8). Metal-Ybt complexes were produced by adding 
iron(III) chloride, copper(II) sulfide, gallium(III) nitrate or nickel(II) nitrate (Sigma) to apo-Ybt. 
Metal-Ybt was applied to a methanol conditioned C18 silica column (Sigma) and eluted with 
80% methanol as previously described (9). Lyophilizer was used to concentrate the eluate 
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overnight. Dried samples were resuspended in deionized water and purified through high-
performance liquid chromatography using C18 silica column (Whatman Partisil). Metal-Ybt 
containing fractions were collected, dried down using a lyophilizer and resuspended in deionized 
water. Stock metal-Ybt quantification was carried out using previously described extinction 
coefficient (9). Sample metal-Ybt levels were quantified in multiple reaction monitoring mode 
using known collision-induced dissociation fragmentations and 13C-labeled Fe(III)-Ybt internal 
standards.  
 
Fe(III)-Ybt dependent growth 
After overnight growth in M63 media, strains were normalized for starting OD600 in M63 with 2 
mM EDDHA (Complete Green Company). 1 µM HPLC-purified Fe(III)-Ybt was added to 
strains and grown for 18 hours in 37 °C with shaking, as previously described (9). Bacterial 
growth was measured using OD600 readings.  
 
Liquid chromatography-mass spectrometry 
LC-MS analyses were conducted using a Shimadzu UFLC-equipped AB-Sciex 4000 QTrap 
operated in positive ion mode using a Turbo V ESI ion source and a Thermo LCQ Deca as 
previously described (8). The samples were injected onto a Fused-core phenylhexyl column 
(Ascentis Express, Supelco) with a flow rate of 0.4ml min-1 and following solvents: solvent A 
(0.1% (v/v) formic acid) and solvent B (90% (v/v) acetonitrile in 0.1% formic acid (v/v)). The 
ion spray voltage was set to 5kV and heater temperature was 500°C. The declustering potential, 
nebulizer gas (G1), auxiliary gas (G2) and collision energy were set at 110V, 40V, 35V and 35V, 
respectively.  
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Cell-associated metal-Ybt 
Strains were grown overnight in M63 minimal salts media with supplements as described above. 
Strains were diluted OD600 of 0.8 in M63 with supplements described above. HPLC-purified 
0.1µM metal-Ybt was added to strains and grown for 2 hours in 37 degrees while shaking. 
Bacteria were pelleted at 7500 g for 10 minutes (Eppendorf) and washed with 1X PBS (Sigma). 
Supernatant was collected and applied to a conditioned C18 silica column with added 13C-
labeled Fe(III)-Ybt internal standard. Bacteria were resuspended in 100% ethanol (Sigma) and 
pelleted at 20,000 g for 10 minutes. Supernatant was collected and dried for 3 hours using a 
vacuum concentrator. Samples were resuspended in ultrapure water and applied to a conditioned 
C18 silica column with added 13C-labeled Fe(III)-Ybt internal standard. Metal-Ybt quantification 
was carried out in the multiple reaction monitoring mode using known collision-induced 
dissociation fragmentations and 13C-labeled Fe(III)-Ybt internal standards as done previously 
(9). 
 
Fe(III)-Ybt reduction 
Bathophenanthrolinedisulfonic acid disodium salt hydrate (BPDS, Sigma), glutathione reduced 
(Sigma), L-ascorbic acid (Sigma) were prepared in phosphate buffered saline pH 7.4 (PBS, 
Sigma). Samples were appropriately mixed in a 96 well plate and incubated for 2 hours at room 
temperature. Spectrophotometrical changes were monitored at 535nm using standard UV/Vis 
spectrometer. Samples were applied to conditioned C18 silica columns and Ybt quantification 
was carried out in the multiple reaction monitoring mode using known collision-induced 
dissociation fragmentations as done previously (9). 
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64Cu(II)-Ybt Radiolabeling 
64Cu (t1/2= 12.7 h, β+=17%, β-=39%, EC=43%, Emax=0.656 MeV) produced by a (p,n) reaction on 
enriched 64Ni on a CS-15 biomedical cyclotron (Cyclotron Corporation, Berkeley, CA) at 
Mallinckrodt Institute of Radiology, Washington University School of Medicine and purified an 
automated system using standard procedures (10, 11). All radioactive procedures were conducted 
in the Department of Radiation Oncology premises under the guidance and authorization of Drs. 
Buck E. Rogers and Nilantha Bandara. A stock solution of 64Cu in 0.05 M HCl received from the 
production team was diluted in 0.1 M ammonium acetate (NH4OAc) buffer solution (pH 7) for 
radiolabeling purposes. Apo-Ybt sample with a known concentration (250 µM) was used.  
A typical reaction involves using 74 – 111 MBq of 64Cu was added to 20 µL of Apo-Ybt (5 
nmol) and 0.1 M NH4OAc buffer added to bring the reaction volume to 100 µL. The reaction 
mixture was incubated incubated on a mixer with 800 rpm agitation at 37 °C for 1 hour. Labeling 
efficiency and radiochemical purity were determined using radio-high performance liquid 
chromatography (Agilent 1200 system with a Flow-RAM radio-HPLC detector) on a C18 
column (Kinetex, Phenomenex).  The mobile phase consisted of water (A) and acetonitrile (B) 
with a gradient of 0 – 100 % B over 10 min using a flow rate of 1 mL/min. The retention time of 
64Cu-Ybt was 6.1 min and a radiochemical yield of greater than 99 % was achieved and used 
without further purification.  
 
Cell-associated 64Cu(II)-Ybt 
Strains were grown overnight in M63 minimal salts media with supplements as described above. 
Strains were diluted OD600 of 0.8 in M63 with supplements described above. HPLC-purified 
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0.1µM Cu(II)-Ybt and 64Cu(II)-Ybt were added to strains and grown for 2 hours while shaking. 
Bacteria were pelleted at 7500 g for 10 minutes (Eppendorf) and washed with 1X PBS (Sigma) 
multiple times. Cell-associated 64Cu levels were measured from pelleted bacteria using a gamma 
counter (Packard II, Perkin Elmer). 
 
Statistical analyses 
Statistics and graphs were generated using GraphPad Prism 5 (GraphPad software). Student’s t-
test was used to compare growth differences and cell-associated metal-Ybt levels between paired 
strains.  
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RESULTS 
FyuA and YbtPQ are necessary and sufficient for Fe(III)-Ybt dependent growth in UPEC 
To confirm UPEC-encoded FyuA and YbtPQ are sufficient for UPEC growth under Fe(III)-Ybt 
dependent conditions, we used the ybtA-deletion mutant background in the model UPEC strain 
UTI89, which has lower expression of genes associated with Ybt biosynthesis and transport on 
the Yersinia HPI (1, 2). FyuA and YbtPQ were ectopically expressed to assess Ybt transport and 
utilization. We measured growth of UTI89ΔybtA in M63 minimal salts media containing 1µM 
purified Fe(III)-Ybt and the iron chelator EDDHA. UTI89ΔybtA pfyuA pybtPQ growth exceeded 
that of UTI89ΔybtA and UTI89ΔybtA pfyuA in the presence but not absence of Fe(III)-Ybt (Fig 
1). The ability of only UTI89ΔybtA pfyuA pybtPQ to promote Fe(III)-Ybt dependent growth is 
consistent with the current model that FyuA and YbtPQ are required and sufficient for Fe(III)-
Ybt dependent growth (16).  
 
YbtPQ-dependent Fe(III)-Ybt transport and recycling 
To determine whether UPEC use FyuA and YbtPQ to import Fe(III)-Ybt complexes, we used 
stable isotope dilution mass spectrometry (LC-MS/MS) to directly measure exogenously-
supplied metal-yersiniabactin complexes (16). In this approach, Fe(III)- and apo-Ybt were 
quantified in culture supernatants and cell extracts following a 2 hour exposure to 0.1µM purified 
Fe(III)-Ybt. Using the ybtA-deletion background ensured no native Ybt synthesis with Ybt 
complexes detected only from those exogenously supplied. Supernatant Fe(III)-Ybt levels were 
nearly eliminated in UTI89ΔybtA pfyuA and UTI89ΔybtA pfyuA pybtPQ suggesting intracellular 
localization of Fe(III)-Ybt (Fig 2A). Consistent with FyuA-mediated transport of Fe(III)-Ybt to 
the periplasm (16), cell-associated Fe(III)-Ybt levels were significantly increased in UTI89ΔybtA 
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pfyuA compared to UTI89ΔybtA. Interestingly, in presence of both FyuA and YbtPQ, cellular 
Fe(III)-Ybt were significantly decreased compared to UTI89ΔybtA pfyuA (Fig 2B). As FyuA and 
YbtPQ are sufficient for Fe(III)-Ybt dependent growth, we hypothesized that intracellular 
Fe(III)-Ybt complex is dissociated to iron and apo-Ybt in UTI89ΔybtA pfyuA pybtPQ, with apo-
Ybt subsequently secreted back to the supernatant. When we examined the culture supernatants 
for apo-Ybt, apo-Ybt levels were significantly increased in UTI89ΔybtA pfyuA pybtPQ 
compared to UTI89ΔybtA and UTI89ΔybtA pfyuA (Fig 2C). These observations support a model 
in which FyuA and YbtPQ are required for Fe(III)-Ybt transport, and YbtPQ-dependent transport 
subsequently leads to iron release from the Fe(III)-Ybt complex with the resulting apo-Ybt 
recycled to the supernatant.  
 
Fe(III)-Ybt transport and utilization by pathogenic E. coli 
To determine if wild type pathogenic E. coli isolates can utilize Fe(III)-Ybt, we examined a 
model UPEC strain, CFT073, which encodes genes on the Yersinia HPI including FyuA and 
YbtPQ, but does not synthesize Ybt due to mutations in the biosynthetic machinery (4–6). We 
compared growths of wild type pathogenic E. coli strains UTI89 and CFT073 with non-
pathogenic strain MG1655 in M63 minimal salts media containing 1µM purified Fe(III)-Ybt and 
the iron chelator EDDHA. Both UTI89 and CFT073 growth exceeded that of MG1655 in the 
presence but no absence of Fe(III)-Ybt (Fig 3). UTI89 did show increased growth in EDDHA-
chelated media with and without Fe(III)-Ybt compared to CFT073, which may be attributed to 
UTI89’s native Ybt biosynthesis. To examine whether CFT073 can recycle apo-Ybt from 
exogenous-supplied Fe(III)-Ybt, we used LC-MS/MS methods as above to measure supernatant 
Fe(III)- and apo-Ybt levels following a 2 hour exposure to 0.1µM purified 13C-salicylate-labeled 
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Fe(III)-Ybt-13C6. Supernatant Fe(III)-Ybt-13C6 levels were nearly eliminated in UTI89 and 
CFT073 compared to MG1655 (Fig 4A, B), while apo-Ybt-13C6 levels were significantly 
increased in UTI89 and CFT073 (Fig 4C, D). Apo-Ybt-13C6 levels were significantly greater in 
UTI89 compared to CFT073, which may be due to a carrier effect from native Ybt synthesis by 
UTI89. These findings show that wild type pathogenic E. coli strains can transport Fe(III)-Ybt 
and recycle the resulting apo-Ybt, and is also consistent with previous findings that Ybt transport 
and recycling are independent of Ybt biosynthesis.  
 
Mechanisms of metal-Ybt dissociation  
The molecular sequence of events by which iron is released from intracellular Fe(III)-Ybt 
complex is incompletely understood, as enzymes associated with Fe(III)-Ybt dissociation have 
yet to be identified on the Yersinia HPI (6, 21). Previously identified mechanisms of iron release 
in other siderophore systems include siderophore degradation as well as reduction of the 
coordinated iron(III) to iron(II), which has significantly lower binding affinity for the 
siderophore (8–11). We have shown above that apo-Ybt is detected in the culture supernatant 
from exogenously supplied Fe(III)-Ybt, suggesting intact Ybt recycling upon iron release. 
Therefore we hypothesized that reduction of Fe(III) to Fe(II) may be the mechanism of iron 
release from Fe(III)-Ybt.  
 
To investigate this, we used physiological reducing agents, ascorbic acid and glutathione (12, 
13), and Bathophenanthroline (BPDS), a strong Fe(II) chelator, to examine iron release from 
Fe(III)-Ybt (14). We mixed 5µM HPLC-purifed Fe(III)-Ybt with 2.5mM BPDS and 50mM 
reducing agents for 2 hours at room temperature in pH 7 and measured Fe(II)-BPDS complex 
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formation (λmax = 533nm). Fe(II)-BPDS formation was significantly increased with both ascorbic 
acid and glutathione, compared to Fe(III)-Ybt and BPDS control (Fig 5A). To determine changes 
in apo-Ybt levels, the reaction was stopped by eluting over a C18 column and changes in apo- 
and Fe(III)-Ybt levels were measured using LC-MS/MS. Consistent with increased Fe(II)-BPDS 
complex formation, we found significant increase in apo-Ybt to Fe(III)-Ybt ratios in presence of 
both ascorbic acid and glutathione (Fig 5B). Interestingly, ascorbic acid led to significantly 
greater apo-Ybt formation compared to glutathione, which is consistent with previous studies 
that showed ascorbic acid to be more efficient compared to glutathione (14–16).  
 
To further examine the mechanism of iron release from Fe(III)-Ybt, we examined the 
intracellular fate of Ga(III)-Ybt. Gallium(III) has similar properties to Fe(III) including atomic 
radius, coordination chemistry and charge, which allows Ga(III) to substitute for Fe(III) and 
disrupt many biomolecular processes (17–19). However, unlike Fe(III), Ga(III) cannot be 
reduced to Ga(II) under physiological conditions (20, 21). We quantified Ga(III)- and apo-Ybt 
from culture supernatants and cell extracts following a 2 hours exposure to 0.1µM purified 
Ga(III)-Ybt. Supernatant Ga(III)-Ybt levels were nearly eliminated in UTI89ΔybtA pfyuA and 
UTI89ΔybtA pfyuA pybtPQ demonstrating Ga(III)-Ybt transport (Fig 6A). Consistent with 
FyuA-mediated transport of Ga(III)-Ybt to the periplasm, cell-associated Ga(III)-Ybt levels were 
significantly increased in UTI89ΔybtA pfyuA compared to UTI89ΔybtA. However unlike Fe(III)-
Ybt, no significant differences in cellular Ga(II)-Ybt levels were detected between UTI89ΔybtA 
pfyuA and UTI89ΔybtA pfyuA pybtPQ (Fig 6B). Consequently, apo-Ybt was also not detected in 
the supernatant of all the strains tested (Fig 6C). These findings suggest that gallium is not 
released from the intracellular Ga(III)-Ybt complex unlike Fe(III)-Ybt, and combined with 
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results from in vitro reduction of Fe(III)-Ybt, support a model in which iron is released from 
intracellular Fe(III)-Ybt through reduction of Fe(III) to Fe(II).  
 
YbtPQ-dependent Cu(II)- and Ni(II)-Ybt transport and recycling 
To determine whether UPEC can transport and dissociate non-iron metal-Ybt complexes, we 
used stable isotope dilution mass spectrometry (LC-MS/MS) to directly measure exogenously-
supplied metal-yersiniabactin complexes. In this approach, Cu(II)-, Ni(II)- and apo-Ybt could be 
quantified in culture supernatants and cell extracts following a 2 hour exposure to 0.1µM purified 
Cu(II)- or Ni(II)-Ybt. Supernatant Cu(II)- and Ni(II)-Ybt levels were nearly eliminated in 
UTI89ΔybtA pfyuA and UTI89ΔybtA pfyuA pybtPQ suggesting intracellular localization of 
Cu(II)- and Ni(II)-Ybt (Fig 7AB). Consistent with FyuA-mediated transport of Cu(II)- and 
Ni(II)-Ybt to the periplasm shown previously, cell-associated Cu(II)- and Ni(II)-Ybt levels were 
significantly increased in UTI89ΔybtA pfyuA compared to UTI89ΔybtA. In presence of both 
FyuA and YbtPQ, cellular Cu(II)- and Ni(II)-Ybt levels were significantly decreased compared 
to UTI89ΔybtA pfyuA (Fig 7CD). When we examined the culture supernatants for apo-Ybt, apo-
Ybt levels were significantly increased in UTI89ΔybtA pfyuA pybtPQ from both from 
exogenously supplied Cu(II)- and Ni(II)-Ybt (Fig 7EF). These observations support a model in 
which similar to the fate of Fe(III)-Ybt, YbtPQ-dependent transport of Cu(II)- and Ni(II)-Ybt 
complexes subsequently leads to metal release from the metal-Ybt complex with the resulting 
apo-Ybt recycled to the supernatant. These findings also raise the possibility that Ybt may act as 
a metallophore to import and utilize select metal-Ybt complexes during infections.  
 
Copper from Cu(II)-Ybt remains intracellular 
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The fate of copper released from intracellular Cu(II)-Ybt upon YbtPQ-dependent transport 
remains unclear. E. coli has several known enzymes that require copper for their function (55–
60). However there are also copper resistance mechanisms that are sensitive to changes in 
intracellular copper levels, including efflux mechanisms to export excess copper (24, 28–30). To 
determine whether the released copper remains intracellular, we used radiolabeled 64Cu(II)-Ybt 
to directly localize 64Cu from exogenously supplied 64Cu(II)-Ybt. In this approach, 64Cu levels 
were measured in cell pellets following a 2 hour exposure to 0.1µM purified Cu(II)-Ybt and 
64Cu(II)-Ybt. 64Cu levels were significantly increased in UTI89ΔybtA pfyuA compared to 
UTI89ΔybtA, consistent with FyuA-mediated transport of Cu(II)-Ybt. Interestingly, no 
significant differences in 64Cu levels were observed between UTI89ΔybtA pfyuA and 
UTI89ΔybtA pfyuA pybtPQ (Fig 8). This was in contrast to intact Cu(II)-Ybt levels between 
these two strains (Fig 7C). These findings combined show that in the presence of both FyuA and 
YbtPQ, copper is released from transported Cu(II)-Ybt and remains intracellular. Copper ions 
delivered from Cu(II)-Ybt may then act as cofactors to E. coli cuproenzymes during infections. 
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DISCUSSION 
In this study, we use direct mass spectrometric detection to show that in presence of Ybt 
importers FyuA and YbtPQ, Ybt delivers physiologically relevant metal ions Fe(III), Cu(II) and 
Ni(II). Iron is released from Ybt through reduction of bound Fe(III) to Fe(II), resulting in intact 
apo-Ybt dissociation and recycling. This however is not seen for Ga(III)-Ybt complex, in which 
gallium ion is not released from Ybt and is consistent with reduction as the mechanism of metal 
release from Ybt. We also show Ybt import and recycling in wild type pathogenic E. coli isolates 
that do not synthesize Ybt but express transport genes on the Yersinia HPI, suggesting Ybt 
cheater strains may benefit during polymicrobial infections with Ybt synthesizing strains. 
Together these findings provide new evidence for a metallophore function by the yersiniabactin 
system that delivers physiologic metal ions to UPEC. 
 
Within an intracellular vesicle, such as the macrophage phagolysosome, UPEC are confined in 
an environment where copper ions may be in excess while iron is limiting (1). In such 
environments where copper is abundant, Ybt has been shown to protect UPEC in a transport-
independent manner (2, 3). Recent work has also shown preference for Fe(III)-Ybt in high local 
Cu(II)-Ybt concentrations by FyuA, suggesting that the yersiniabactin import system may be 
adapted to a range of copper concentrations (4). As such, our observations showing copper 
release from intracellular Cu(II)-Ybt at relatively low copper concentrations suggest in 
environments where copper may be limiting, Ybt may deliver copper to UPEC. Although it is 
unclear whether the host deliberately limits copper levels to limit microbial growth, 
Cryptococcus neoformans has been shown to encounter copper limitation during brain-stage of 
infection, resulting in increased expression of fungal copper transporters (64, 65). Further 
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investigation is necessary to determine whether similar environments are encountered during 
urinary tract pathogenesis.  
 
The ability of Cu(II) and Ni(II)-Ybt complexes to be transported and dissociated through the 
same pathway as Fe(III)-Ybt suggests promiscuous interactions with Ybt transporters as well as 
with potential reductases. Furthermore the intracellular release of reactive Cu(I) and Ni(I) ions 
from Ybt may require chaperones that interact with these ions and prevent any unwanted 
consequences of labile ions. Small molecule chelators such as glutathione have been shown to be 
critical for E. coli copper homeostasis in the absence of cytoplasmic copper efflux mechanisms 
(7). Furthermore metallothioneins have been shown to sequester intracellular copper in fungal 
pathogens and recent work describing a novel metallothionein in Mycobacterium tuberculosis 
suggest bacterial pathogens may also possess cytoplasmic copper chaperones that are yet to be 
identified (6, 8, 9). Thus far all known copper-dependent enzymes in E. coli are periplasmic or 
embedded in the cytoplasmic membrane (10). The cytoplasmic requirement for copper may be 
unclear, but recent work by Osman et al., has shown inner membrane copper efflux ATPases to 
be required for Salmonella Cu, Zn-superoxide dismutase activity (11). A requirement for copper 
to first be transported to the cytoplasm prior to being loaded on cuproenzymes may uncover 
novel interactions among bacterial copper homeostatic machinery and copper-dependent 
proteins.  
 
Microbial pathogens encounter numerous physiologic environments during infection 
pathogenesis where the host changes the availability of transition metals to limit microbial 
growth (12). Ybt provides a gain-of-function through its interactions with iron, copper and 
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possibly with other physiologic metal ions (2). In addition, recycling of apo-Ybt may allow 
pathogens to effectively conserve scarce resources during an infection without constant de novo 
siderophore synthesis (13, 14). These properties may benefit a polymicrobial UPEC infection 
community as a whole, including cheater strains, by synthesizing and maintaining physiologic 
Ybt concentrations with relatively minor costs for the population.  
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CHAPTER FOUR: FIGURES 
 
Figure 1. FyuA and YbtPQ are required and sufficient for Fe(III)-Ybt-dependent growth 
in UPEC. Growth of UTI89ΔybtA (black circle), UTI89ΔybtA pfyuA (red square), and 
UTI89ΔybtA pfyuA pybtPQ (blue triangle) all show decreased growth in EDDHA-chelated M63 
minimal salts media (A), while growth is rescued for UTI89ΔybtA pfyuA pybtPQ upon addition 
of 1µM Fe(III)-Ybt to chelated media (B). Results are shown as mean ± s.d.; n=3. 
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Figure 2. Direct LC-MS/MS detection of supernatant and cell-associated Fe(III)- and apo-
Ybt in FyuA and YbtPQ-expressing UTI89. Bacteria grown in media containing 0.1µM 
Fe(III)-Ybt were extracted to quantify supernatant and cellular Fe(III)- and apo-Ybt levels using 
LC-MS/MS with a 13C-labeled Fe(III)-Ybt internal standard. (A) Supernatant Fe(III)-Ybt 
remained extracellular in transport-deficient UTI89ΔybtA. (B) Exogenous FyuA expression in 
UTI89ΔybtA significantly increased cell-associated Fe(III)-Ybt levels, but expression of both 
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FyuA and YbtPQ resulted in decreased cellular Fe(III)-Ybt levels. (C) Apo-Ybt was recycled to 
the supernatant in UTI89ΔybtA pfyuA pybtPQ. Results are shown as nanomoles, mean ± s.d.; 
n=3; ****P < 0.0001.   
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Figure 3. Growth of pathogenic E. coli strains under Fe(III)-Ybt-dependent conditions. 
Pathogenic strains, UTI89 (black circle) and CFT073 (blue square), and non-pathogenic 
MG1655 (red triangle) all show limited growth in EDDHA-chelated M63 minimal salts media 
(A). Growth is rescued for both UTI89 and CFT073 upon addition of 1µM Fe(III)-Ybt to 
chelated media (B). Results are shown as mean ± s.d.; n=3.  
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Figure 4. Direct LC-MS/MS detection of Fe(III)- and apo-Ybt from pathogenic E. coli 
culture supernatant. Supernatant from strains grown in 0.1µM 13C-salicylate-labeled Fe(III)-
Ybt-13C6 were extracted to quantify Fe(III)-Ybt-13C6 and apo-Ybt-13C6 levels. (A) Representative 
LC-MS/MS chromatogram of supernatant Fe(III)-Ybt-13C6 scaled to internal standard peaks. (B) 
Supernatant Fe(III)-Ybt-13C6 levels were significantly decreased in UTI89 and CFT073. (C) 
Representative LC-MS/MS chromatogram of supernatant apo-Ybt-13C6 scaled to internal 
standard peaks. (D) Supernatant apo-Ybt-13C6 levels were significantly increased in UTI89 and 
CFT073. Results are shown as nanomoles, mean ± s.d.; n=3; ****P < 0.0001.   
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Figure 5. In vitro iron release from Fe(III)-Ybt complexes. HPLC-purified Fe(III)-Ybt (5µM) 
were mixed with BPDS (Bathophenanthrolinedisulfonic acid, 2.5mM) and excess reducing 
agents (50mM) in PBS buffer pH7.0 for 2 hours. Addition of reducing agents, ascorbic acid and 
glutathione, showed significant increase in (A) Fe(II)-BPDS complex formation (λmax = 533nm), 
as well as (B) apo-Ybt determined through apo- and Fe(III)-Ybt ion chromatogram peak ratios 
using LC-MS/MS. Results are shown as mean ± s.d.; n=3; ****P < 0.0001. 
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Figure 6. Direct LC-MS/MS detection of supernatant and cell-associated Ga(III)- and apo-
Ybt in FyuA and YbtPQ-expressing UTI89. Bacteria grown in media containing 0.1µM 
Ga(III)-Ybt were extracted to quantify supernatant and cellular Ga(III)- and apo-Ybt levels using 
LC-MS/MS with a 13C-labeled Fe(III)-Ybt internal standard. (A) Supernatant Ga(III)-Ybt 
remained extracellular in transport-deficient UTI89ΔybtA. (B) Cellular Ga(III)-Ybt levels were 
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not significantly different in UTI89ΔybtA pfyuA and UTI89ΔybtA pfyuA pybtPQ. (C) Apo-Ybt 
was not detected (ND) in the supernatants of strains tested. Results are shown as nanomoles, 
mean ± s.d.; n=3; ****P < 0.0001.    
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Figure 7. Direct LC-MS/MS detection of supernatant and cell-associated Cu(II)-, Ni(II)- 
and apo-Ybt in FyuA and YbtPQ-expressing UTI89. Bacteria grown in media containing 
0.1µM Cu(II)- (left) or Ni(II)-Ybt (right) were extracted to quantify supernatant and cellular 
Cu(II)-Ybt Ni(II)-Ybt
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Cu(II)-, Ni(II)- and apo-Ybt levels using LC-MS/MS with a 13C-labeled Fe(III)-Ybt internal 
standard. (A, B) Supernatant Cu(II)- and Ni(II)-Ybt remained extracellular in transport-deficient 
UTI89ΔybtA. (C, D) Exogenous FyuA expression in UTI89ΔybtA significantly increased cell-
associated Cu(II)- and Ni(II)-Ybt levels, but expression of both FyuA and YbtPQ resulted in 
decreased cellular Cu(II)- and Ni(II)-Ybt levels. (E, F) Apo-Ybt was recycled to the supernatant 
in UTI89ΔybtA pfyuA pybtPQ. Results are shown as nanomoles, mean ± s.d.; n=3; ****P < 
0.0001.    
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Figure 8. Direct detection of 64Cu from cellular 64Cu(II)-Ybt. Bacteria grown in media 
containing 0.1µM Cu(II)-Ybt and 64Cu(II)-Ybt were extracted to quantify cellular 64Cu levels. 
Cellular 64Cu levels were not significantly different in UTI89ΔybtA pfyuA and UTI89ΔybtA 
pfyuA pybtPQ. Results are shown as counts per minute, mean ± s.d.; n=3; *****P < 0.00001. 
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5.1 Summary of the Thesis 
This thesis describes the interactions between the yersiniabactin siderophore system and metal 
ions in the context of uropathogenic Escherichia coli (UPEC) pathogenesis in the urinary tract. 
Yersiniabactin (Ybt) confers a gain-of-function to UPEC through its interactions with both iron 
and copper ions during infection, and Ybt’s interaction with copper has been shown to protect 
UPEC against host copper ions as well as oxidative stress (1, 2). However it has been unclear 
whether UPEC imports Cu(II)-Ybt complexes similar to Fe(III)-Ybt, and how Ybt transport 
impacts UPEC pathogenesis.  
 
We investigated the interactions of Ybt with other physiologic transition metals and whether 
non-ferric metal-Ybt complexes were transport substrates of FyuA, the Fe(III)-Ybt outer 
membrane importer (3). Using a constant neutral loss LC-MS/MS screen, we showed Ybt 
complexes with nickel(II), cobalt(III) and chromium(III), in addition to previously described 
complexes with iron(III), gallium(III) and copper(II). All stable metal-Ybt complexes were 
transported through FyuA to the periplasm in TonB-dependent manner. Of these, Cu(II)-Ybt was 
the only complex not to competitive inhibit Fe(III)-Ybt transport. We next investigated the role 
of Ybt inner membrane transporters YbtP and YbtQ during UPEC pathogenesis. Using an 
experimental murine chronic cystitis model, we found that the YbtPQ-deficient strain showed a 
significant, million-fold competitive defect against the wild type in high titer bladder infections. 
We next examined the fate of metal-Ybt complexes upon transport through YbtPQ to investigate 
whether Ybt delivers metal ions in addition to iron. We found that in presence of both FyuA and 
YbtPQ, Fe(III)-, Cu(II)- and Ni(II)-Ybt import leads to the metal being released from Ybt and 
the resulting metal-free apo-Ybt recycled. 
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These findings support a model in which Ybt acts as a metallophore that can deliver select 
physiologic metal ions to UPEC (Fig 1). The Ybt system may therefore be fine-tuned for varying 
host environments to provide a gain-of-function for UPEC. Overall, studies in this thesis present 
a unique paradigm for E. coli copper transport and homeostasis in the urinary tract.  
 
5.2 Perspectives on metal availability in the urinary tract 
For pathogenic bacteria, adaptation to host environments is a vital component for establishing an 
infection and persisting within the host. To defeat the intruding pathogen, the host can 
deliberately limit the availability of specific transition metals to prevent pathogens from 
acquiring these vital cofactors, while also increasing the availability of metals such as copper as 
an antimicrobial strategy (4–6). Therefore depending on the circumstances, the pathogen must 
sense and counter these changes in the microenvironment. The experimental cystitis model used 
in this thesis is characterized by a robust inflammatory response and populations of intracellular 
UPEC within urothelial cells, macrophages and neutrophils (7, 8). Results from this thesis show 
Ybt import providing a fitness advantage to UPEC in these conditions, suggesting the acquisition 
of metals through Ybt is important for overcoming the effects of nutritional immunity by the 
host. Furthermore, previous works have shown Ybt-mediated protection through sequestration of 
copper ions and interfering with the reactive oxygen species responses in intracellular 
compartments (1, 2). The findings in this thesis are consistent with these observations as Fe(III)-
Ybt is preferentially imported in high Cu(II)-Ybt conditions to prevent excess copper import 
while maintaining iron transport (3). By protecting UPEC while selecting for iron transport, Ybt 
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may allow UPEC survival and persistence within immune cells, which in turn may permit 
dissemination beyond the urinary tract.  
 
In contrast to the copper-rich environments as described above, there may exist 
microenvironments with low copper availability that may require copper delivery through Ybt. It 
is interesting to note that Cryptococcus neoformans, an opportunistic fungal pathogen encounters 
varying copper availability during different stages of infection. Upon dissemination to the brain, 
C. neoformans encounters an environment deprived of copper and in response, expresses copper 
transporters (9–11). Although it is unclear whether UPEC encounters a similar host environment, 
it does suggest a potential strategy used by the host where copper availability is limited as 
opposed to in excess. Further studies investigating the metal availability and host responses 
within urinary tract environments will allow better understanding of Ybt’s role in UPEC 
pathogenesis.    
 
5.3 Implications and outcomes of metallophore transport  
The process of siderophore import and metal acquisition requires multiple steps (12–14). The 
data presented in this thesis provides new insight into our understanding of Ybt’s recognition and 
transport by membrane transporters as well as its intracellular fate. Although multiple metal-Ybt 
complexes are recognized and imported by the TonB-dependent outer membrane transporter 
FyuA, the preference for Fe(III)-Ybt over Cu(II)-Ybt import suggests distinct binding 
interactions between metal-Ybt complexes and FyuA. This is consistent with theoretical 
structural modeling data supporting a distinctive Cu(II)-Ybt structure from those of other metal-
Ybt complexes including Fe(III)-Ybt (3). Although residues in the core β-barrel domain are 
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heavily conserved among numerous TonB-dependent transporters (TBDT), the extracellular 
loops are essential for distinct cargo recognition (12). Furthermore, binding of a siderophore to 
these receptors transduces a signal that may trigger conformational changes and reveal new 
binding sites (15, 16). Structural analyses investigating the interactions between different metal-
Ybt complexes and FyuA could provide insight to FyuA’s Cu(II)-Ybt-specificity. TBDT have 
been the subject of numerous structural investigations to engineer transport substrates that 
specifically target Gram-negative pathogens (12, 17). Novel binding sites by metal-Ybt 
complexes may therefore act as targets for future TBDT-dependent inhibitors.  
 
In addition to FyuA, iron acquisition using Ybt requires the inner membrane transporters YbtP 
and YbtQ (18). The findings in this thesis support a model in which metal-Ybt transport through 
FyuA and YbtPQ results in metal release and Ybt recycling. Overall, FyuA has been studied in 
greater detail compared to YbtPQ, in terms of both infection and mechanistic studies. As such, 
there are several unanswered questions regarding YbtPQ and the fate of metal-Ybt complexes 
that may provide further insight to this system. Compared to other siderophore systems in E. coli 
such as enterobactin, enzymes associated with metal release from Ybt have yet to be identified 
(19, 20). Results from this thesis show metal reduction as a potential mechanism of metal release 
from Ybt. Reduction of Fe(III) to Fe(II) is a proposed model of iron release for several 
siderophore systems in Gram-negative bacteria, including pyoverdine in Pseudomonas 
aeruginosa and mycobactin in Mycobacterium tuberculosis (21, 22). Recent work describing a 
novel siderophore reductase YqjH in E. coli that can release iron from hydrolyzed enterobactin 
and other catecholate siderophores suggest specific reductases may exist for structurally similar 
siderophores (20). It is unclear whether yersiniabactin, a phenolate siderophore, is a substrate of 
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YqjH. Furthermore, as several Gram-negative pathogens including uropathogenic E. coli, 
Klebsiella pneumonia and Yersinia pestis synthesize yersiniabactin (1, 14, 23), it will be of 
interest to investigate whether a putative Ybt reductase is conserved in these pathogens away 
from the Yersinia high pathogenicity island. Identification of a Ybt reductase that is conserved 
among these pathogens may provide an additional therapeutic target.  
 
The intracellular dissociation of Fe(III)-, Cu(II)- and Ni(II)-Ybt complexes results in an intact 
Ybt molecule and a metal ion. Due to the reactive properties of these metals, they may be rapidly 
bound to chaperones upon release from Ybt. In the case of iron, the classic cargo for 
siderophores, previous works have shown glutathione or phosphorylated sugar derivatives as the 
Fe(II) chaperone prior to transfer to the iron storage protein ferritin or to iron-dependent enzymes 
(24, 25). However as for copper and nickel, the mechanisms of storage and distribution to 
metalloproteins is unclear. E. coli have several copper defense mechanisms that are extremely 
sensitive to changes in intracellular copper levels (5, 26, 27). Therefore UPEC must have 
mechanisms to maintain balance of intracellular copper. Similar to Fe(II), glutathione has also 
been proposed as a cytoplasmic copper chelator (28). Recent discovery of metallothioneins in 
Mycobacterium tuberculosis suggest these efficient copper chelators, previously studied in 
eukaryotes models, may also be present in bacteria (10, 29, 30). From these chelators, it is 
unclear how copper is delivered to E. coli cuproenzymes, which are to date, all periplasmic or 
embedded in the inner membrane (31–33). Recent work suggesting copper efflux ATPases as 
copper delivery pumps for the Salmonella Cu, Zn-superoxide dismutase, suggests novel 
pathways for copper delivery from the cytoplasm to periplasmic or inner membrane 
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cuproenzymes (34). Investigating mechanisms of copper acquisition and incorporation by these 
cuproenzymes would expand our understanding of bacterial copper homeostasis and transport.  
 
The metabolic cost that goes into synthesizing siderophores may be significant during an 
infection where pathogens are under stress to survive. Recycling of intact siderophores, including 
Ybt, allows pathogens to conserve scarce resource without constantly synthesizing new 
siderophore molecules (35, 36). In the case of UPEC, which can encode several siderophore 
systems, Ybt recycling could perhaps be an additional pathogenic gain-of-function in contrast to 
enterobactin, which is hydrolyzed prior to iron release. Siderophores as common goods within a 
bacterial community may suggest these class of recyclable siderophores to benefit the entire 
bacterial population with relatively minor initial costs. However the evolution of cheater strains 
as well as counter measures to prevent siderophore piracy suggest a strong relationship between 
siderophores and bacteria resource management (37, 38). Further investigations comparing the 
metabolic costs of virulence-associated siderophore systems as well as the prevalence of 
siderophore cheater strains in polymicrobial infections would expand our understanding of the 
process of acquiring new siderophore systems or losing components of existing ones by 
pathogens.  
 
5.4 Methodology development and applications 
The methodologies developed in this thesis provide new approaches to unanswered questions in 
the siderophore field and other areas. The constant neutral loss screen developed by Chaturvedi 
et al., and expanded in this thesis, allow an effective screen to identify stable metabolites with 
known fragmentation properties that may interact with different metal ions (1, 3). Using the 
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constant neutral loss screen, we were able to identify novel metal-siderophore complexes and 
characterize Ybt’s metal profile. Taking these newly identified stable metal-siderophore 
complexes, we developed a quantitative multiple reaction monitoring method to accurately detect 
and quantify these complexes. This could be applied to numerous conditions that require 
sensitive detection such as urine or controlled culture conditions. Metabolite profiling and 
comparisons between clinical isolates using mass spectrometric techniques can provide novel 
insight to the pathogenicity of numerous pathogens (39–41).  
 
Previous works investigating siderophore transport and metal acquisition have utilized 
radiolabeled metals or the fluorescent properties of the siderophore (42–45). The quantitative 
mass spectrometric approached developed in this thesis allows direct comparisons between 
different metal-bound complexes using non-radioactive metals. Furthermore by specifically 
quantifying both metal-bound and apo-siderophore complexes in the same medium, we could 
tract the siderophore as opposed to the metal to describe new mechanisms in siderophore 
localization, dissociation and recycling. This in combination with radiolabeling approaches as 
done in this thesis allow comparisons between the fate of the siderophore and the released metal. 
While the mass spectrometric techniques allow further investigation of mechanisms of 
siderophore dissociation, radioactive metals can also be used as sensitive tools for identifying 
novel co-factors or protein that interact with the imported metal.  
 
5.5 Concluding remarks 
The diversity and physiological functions of small metabolites secreted by pathogenic bacteria 
are areas of great unknowns and interest. This dissertation expands our understanding of the 
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multi-functional properties of bacterial metabolites in the context of metal homeostasis in the 
host-pathogen interface. Examining the balance between metal requirements and availability by 
pathogens may provide a better understanding of the strategies used by pathogens to survive in 
diverse host environments. This thesis also presents an improved understanding of siderophore 
systems and raises new questions on the mechanisms of bacterial metalloenzymes, which remain 
largely uncharacterized (46, 47). With global concerns for rapidly growing antibiotic resistance 
(48), further examination of the relationship between metabolites and microbial systems may 
yield novel functions and therapeutic potentials.  
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CHAPTER FIVE: FIGURES 
 
Figure 1. Metal transport and delivery by the yersiniabactin metallophore system. 
Extracellular apo-Ybt interacts with select transition metals (light blue). Stable metal-Ybt 
complexes are transported through the TonB-dependent outer membrane receptor, FyuA, and 
ATP-binding cassette inner membrane transporters, YbtP and YbtQ. Select metal ions are 
released from intracellular metal-Ybt complexes and apo-Ybt is subsequently recycled to the 
extracellular matrix.  
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